Programme: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Conference day 1

Tuesday, June 6th 2023

8:00 - 9:15, Main arena 1

OPENING SYMPOSIUM: Saving limbs: How a broader PAD approach improves patients' treatment

supported by Abbott Vascular

Moderator:

Dierk Scheinert

Panelist:

Lieven Maene

Panelist:

Marco Manzi

Panelist:

Lorenzo Patrone
1. 08:00 - 08:07
  
  Beyond intervention: Our most important learnings from the journey
2. 08:07 - 08:12
  
  Discussion
3. 08:12 - 08:42
  
  Live case transmission from Leipzig
4. 08:42 - 08:52
  
  Discussion
5. 08:52 - 09:02
  
  How to prevent amputation – my experience working as a multidisciplinary team
6. 09:02 - 09:15
  
  Round table discussion
9:00 - 11:00, Main arena 2

Acute venous thromboembolism

Moderator:

Robert Lookstein

Moderator:

Oliver Schlager

Panelist:

Gary Ansel

Panelist:

Houman Jalaie

Panelist:

Sean Lyden

Panelist:

Manuela Konert
1. 09:00 - 09:20
  
  Live case transmission from Galway
2. 09:20 - 09:27
  
  Effectiveness and safety of ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism: A multinational individual-level data analysis of more than 1500 patients
3. 09:27 - 09:34
  
  FlowTriever embolectomy for acute pulmonary embolism
4. 09:34 - 09:41
  
  Rationale of a pivotal randomized trial comparing aspiration thrombectomy vs medical therapy for intermediate high risk pulmonary embolism
5. 09:41 - 10:01
  
  Live case transmission from Galway
6. 10:01 - 10:08
  
  Prospective post-market clinical follow-up study of the Aspirex™ endovascular thrombectomy system in the treatment of acute venous occlusions – 12-month update
7. 10:08 - 10:15
  
  Catheter-directed thrombolysis and pharmacomechanical thrombectomy for acute deep vein thrombosis
8. 10:15 - 10:30
  
  Recorded case presentation: New technology to address DVT Management and Pulmonary Artery Treatment: Penumbra Lightning™ 12 system, designed for Frontline Aspiration
9. 10:30 - 10:37
  
  Endovascular theombectomy for accute PE with shock
10. 10:37 - 11:00
  
  Discussion
9:00 - 11:15, Technical forum

Status update: Carotid interventions 2023

Moderator:

Peter Schneider

Moderator:

Ralf Langhoff

Panelist:

Eugenio Stabile

Panelist:

Piotr Musialek

Panelist:

Horst Sievert

Panelist:

Eric Ducasse
1. 09:00 - 09:05
  
  Carotid repair is best for asymptomatic carotid stenosis because medical management alone does not work
2. 09:05 - 09:10
  
  Update on the CEA vs CAS trials for asymptomatic carotid stenosis
3. 09:10 - 09:15
  
  Interventions in acute carotid syndrome: When and how?
4. 09:15 - 09:20
  
  Why guidelines can be misleading: Carotid guidelines are an example
5. 09:20 - 09:25
  
  Panel discussion
6. 09:25 - 09:30
  
  Focus on latest technique and new devices: Local anaesthesia and intraoperative ultrasound are the key for an uncomplicated carotid endarterectomy
7. 09:30 - 09:35
  
  Focus on latest technique and new devices: TCAR is better than true percutaneous carotid stenting: Myth or reality?
8. 09:35 - 09:40
  
  Focus on latest technique and new devices: Risk factors of stroke in patients undergoing transcervical and transfemoral carotid stenting
9. 09:40 - 09:45
  
  Focus on latest technique and new devices: FIRST TIME DATA RELEASE: 30-day safety outcomes of male vs female patients treated using the Roadsaver dual-layer micromesh carotid stent: Evidence from a large multicenter European study
10. 09:45 - 09:50
  
  Focus on latest technique and new devices: FIRST TIME DATA RELEASE: 30-day safety outcomes of patients treated using the Roadsaver dual-layer micromesh carotid stent with or without predilatation: Evidence from a large multicenter European study
11. 09:50 - 10:30
  
  Live case transmission from Münster
12. 10:30 - 10:35
  
  Focus on latest technique and new devices: How to select endovascular protection devices for CAS
13. 10:35 - 10:40
  
  Focus on latest technique and new devices: Proximal protection during carotid artery stenting: A preferred solution for all patients
14. 10:40 - 10:45
  
  Focus on latest technique and new devices: Carotid artery stenting with proximal protection: How to optimize your outcomes
15. 10:45 - 10:50
  
  Focus on latest technique and new devices: Experiences from a high volume carotid artery stenting center: Improving safety with proximal protection
16. 10:50 - 10:55
  
  Focus on future concepts: Acute stroke interventions – step-by-step
17. 10:55 - 11:00
  
  Focus on future concepts: Percutaneous exclusion of carotid artery aneurysms: Insights from the C-Heal-trial
18. 11:00 - 11:05
  
  Focus on future concepts: AI with specific algorythms could predict carotid risk lesions for stroke: Revolutionary tool or fake?
19. 11:05 - 11:15
  
  Live case recap and discussion
9:15 - 11:15, Main arena 1

CONNECT THE WORLD SESSION: JAPAN – in collaboration with JET – Innovations and latest data in femoropopliteal interventions

Moderator:

Dierk Scheinert

Moderator:

Osamu Iida

Panelist:

Hiroyoshi Yokoi

Panelist:

Yoshimitsu Soga

Panelist:

Thomas Zeller

Panelist:

Yann Gouëffic

Panelist:

Chris Metzger
1. 09:15 - 09:45
  
  Live case transmission from Tokyo
2. 09:45 - 09:50
  
  FIRST TIME DATA RELEASE: Ranger SFA II RCT (Ranger DCB vs POBA) – 3 year patency and 4 year clinical/safety
3. 09:50 - 09:55
  
  Prospective, multicenter registry of drug-coated balloon treatment for peripheral artery disease: Results from the Japan POPCORN registry
4. 09:55 - 10:00
  
  Korean multicenter prospective registry of IN.PACT drug-coated balloon for Popliteal Artery Disease (K-POP Study)
5. 10:00 - 10:05
  
  1-year outcomes after Paclitaxel-coated balloon angioplasty of femoropopliteal arteries among patients in the french national health data system
6. 10:05 - 10:10
  
  FIRST TIME DATA RELEASE: ELEGANCE registry: DET in under-represented groups – Initial results in the first 750 patients with Ranger DCB
7. 10:15 - 10:45
  
  Live case transmission from Leipzig
8. 10:45 - 10:50
  
  FIRST TIME DATA RELEASE: TINTIN trial investigating the combination of DCB and bare metal stents: 4-year result
9. 10:50 - 10:55
  
  FIRST TIME DATA RELEASE: Real world all comers data from the REGAL registry – 2-year results
10. 10:55 - 11:00
  
  3-year results of the CAPSICUM study
11. 11:00 - 11:05
  
  Advancing SFA lesion treatment with NiTiDES™ self-expanding DES
12. 11:05 - 11:10
  
  A patient-level pooled analysis of drug-coated balloons vs bare metal stents for the treatment of symptomatic femoropopliteal disease
13. 11:10 - 11:15
  
  Live case recap and discussion
11:00 - 11:45, Main arena 2

Ablation therapy for superficial venous disease

Moderator:

Raghu Kolluri

Moderator:

Tobias Hirsch

Panelist:

Thomas Mattausch
1. 11:00 - 11:07
  
  What are the treatment options for Saphenous Ablation?
2. 11:07 - 11:14
  
  When is the VenaSeal Closure system appropriate for patients?
3. 11:14 - 11:21
  
  Single center experience on Saphenous Vein Incompetence study
4. 11:21 - 11:28
  
  Trial updates for chronic venous disease patients enrolled in the spectrum study program: Study design and current status
5. 11:28 - 11:45
  
  Panel discussion
11:00 - 12:00, Scientific posters

Moderated poster round – Challenging cases: AV, Venous, Visceral

Moderator:

Ramon Varcoe
1. 11:00 - 11:05
  
  Endovascular removal of a dislodged Supera stent from a dialysis access arterio-venous graft
2. 11:05 - 11:10
  
  Mechanical thrombectomy in acute thrombosis of dialysis arteriovenous fistulae
3. 11:10 - 11:15
  
  Spectrum of complications associated with hemodialysis catheter insertion
4. 11:15 - 11:20
  
  Innovative and effective solution for treating dysfunctional AV access
5. 11:20 - 11:25
  
  Large pulmonary emboli and paradoxical embolism treated with catheter directed thrombolysis
6. 11:25 - 11:30
  
  Challenging endovascular treatment of a cephalic arch stent fracture in brachiocephalic arteriovenous fistulae
7. 11:30 - 11:35
  
  Acoustic pulse thrombolysis (EKOS), and a suprarenal inferior vena cava filter for the treatment of extensive Inferior Vena Cava thrombosis over pervious Inferior vena cava filter in a case of antithrombin III deficiency
8. 11:35 - 11:40
  
  Iliac vein compression with significant limb swelling caused by lumbosacral exostosis. Its elimination by iliac vein stenting
9. 11:40 - 11:45
  
  A successful case of catheter-directed thrombolysis in a patient with deep vein thrombosis due to idiopathic eosinophilia
10. 11:45 - 11:50
  
  Successful retrieval of an intravascular foreign body using ONE Snare® system
11. 11:50 - 11:55
  
  Surgical bail out after failed endovascular revascularisation for mesenteric ischaemia in systemic lopus victim
11:15 - 12:30, Main arena 1

SYMPOSIUM: From RCTs, to real world, to big data. Moving forward with drug eluting technologies for PAD

supported by Boston Scientific

Moderator:

Marianne Brodmann

Moderator:

Koen Deloose

Panelist:

Giovanni Torsello

Panelist:

Osamu Iida

Panelist:

Yann Gouëffic
1. 11:15 - 11:22
  
  RCT data, the pinnacle of proof
2. 11:22 - 11:29
  
  Real world data
3. 11:29 - 11:36
  
  Real world data from Japan
4. 11:36 - 11:43
  
  Big data from big databases
5. 11:43 - 11:53
  
  Panel discussion: Where we have been, what we have learnt, where we are going.
6. 11:53 - 12:30
  
  Live case transmission from Tokyo
11:15 - 12:30, Technical forum

Innovative endovascular treatment options for complex aorto-iliac pathologies

Moderator:

Maria Antonella Ruffino

Panelist:

Sigrid Nikol

Panelist:

Peter Goverde

Panelist:

Michele Piazza

Panelist:

Nilo Mosquera
1. 11:15 - 11:20
  
  The need for a more specific and disease-severity related score in aortoiliac occlusive disease: ACHELIS ACE score
2. 11:20 - 11:45
  
  Live case transmission from Leipzig
3. 11:45 - 11:50
  
  CERAB – How we do it
4. 11:50 - 11:55
  
  BeGlory study – put evidence to CERAB
5. 11:55 - 12:00
  
  5-years follow-up of subjects with aortoiliac occlusive disease treated with the VIABAHN VBX balloon expandable endoprosthesis
6. 12:00 - 12:05
  
  Complex AIOD treatment with VBX device and Kissing-CERAB technique. When, how, and results
7. 12:05 - 12:10
  
  Long-term outcomes of CERAB
8. 12:10 - 12:15
  
  Endovascular solution for complex pararenal aortic stenoses
9. 12:15 - 12:20
  
  Update on the CoBaGI trial – using covered stents for visceral artery obstructions
10. 12:20 - 12:30
  
  Discussion and conclusion
11:45 - 12:30, Main arena 2

Scrub in with the experts: Deep venous interventions – part I

Moderator:

Chris Metzger

Moderator:

Houman Jalaie

Panelist:

Kush Desai

Panelist:

Michael Piorkowski

Panelist:

Manuela Konert

Panelist:

Rick de Graaf

Panelist:

Erin Murphy
1. 11:45 - 12:00
  
  Live case transmission from Arnsberg
2. 12:00 - 12:05
  
  FLASH PRESENTATION: Deep venous obstruction: Proper patient selection and the utilization of imaging
3. 12:05 - 12:10
  
  FLASH PRESENTATION: Is there an indication for spot-stenting in post-thrombotic iliofemoral obstructions
4. 12:10 - 12:25
  
  Live case transmission from Arnsberg
5. 12:25 - 12:30
  
  FLASH PRESENTATION: When and how to perform endophlebectomy of the common femoral vein in addition to venous recanalization?
12:30 - 13:30, Main arena 1

SPECIAL SESSION: Latest trial data, breakthrough innovations and ongoing controversies in PVD

Moderator:

Peter Schneider

Moderator:

Dierk Scheinert

Panelist:

Robert Lookstein

Panelist:

Osamu Iida

Panelist:

Ramon Varcoe

Panelist:

Gary Ansel

Panelist:

Thomas Zeller

Panelist:

Sahil Parikh
1. 12:30 - 12:38
  
  Focus on latest data for CLTI treatment: The BEST-CLI and BASIL-2 trials: Key findings
2. 12:38 - 12:42
  
  Focus on latest data for CLTI treatment: My take on the results and implications for my practice
3. 12:42 - 12:46
  
  Focus on latest data for CLTI treatment: My take on the results and implications for my practice
4. 12:46 - 12:50
  
  Focus on latest data for CLTI treatment: My take on the results and implications for my practice
5. 12:50 - 13:00
  
  Focus on latest data for CLTI treatment: Panel discussion
6. 13:00 - 13:10
  
  Focus on drug-eluting devices: The Paclitaxel mortality debate – time for regulatory bodies to end this saga?
7. 13:10 - 13:15
  
  Focus on drug-eluting devices: Panel discussion
8. 13:15 - 13:25
  
  Focus on drug-eluting devices: Do we have enough evidence for limus devices to replace PTX?
9. 13:25 - 13:30
  
  Focus on drug-eluting devices: Panel discussion
12:30 - 13:15, Main arena 2

LUNCH SYMPOSIUM: Treatment of CLTI: New horizons with novel DCB technology

supported by MedAlliance

Moderator:

Marianne Brodmann

Panelist:

George Adams

Panelist:

Daniel van den Heuvel

Panelist:

Bella Huasen
1. 12:30 - 12:32
  
  Opening
2. 12:32 - 12:42
  
  Novel SELUTION SLR technology & clinical update
3. 12:42 - 12:47
  
  Discussion
4. 12:47 - 12:52
  
  Rationale & Design of SELUTION4BTK trial
5. 12:52 - 13:02
  
  Treatment of CLTI patients with complex BTK disease – lessons from Selution4BTK randomized clinical trial – Case 1: European Experience
6. 13:02 - 13:12
  
  Treatment of CLTI patients with complex BTK disease – lessons from Selution4BTK randomized clinical trial – Case 2: US Experience
7. 13:12 - 13:15
  
  Discussion
12:30 - 13:30, Speakers' corner

PAIRS@LINC: Challenging venous interventions

Speaker:

Ayman Al Sibaie

Moderator:

Raghu Kolluri
1. 12:30 - 12:38
  
  Varicose veins; Updates in thermal and non thermal ablation
2. 12:38 - 12:46
  
  Sclerotherapy of Endometrioma: How I do it
3. 12:46 - 12:54
  
  Treatment of female genital varices
4. 12:54 - 13:02
  
  PE: Endovascular management
5. 13:02 - 13:10
  
  Endo AVF: What you need to know
6. 13:10 - 13:18
  
  Advanced central venous reconstruction
7. 13:18 - 13:30
  
  Discussion and conclusion
12:30 - 13:15, Technical forum

LUNCH SYMPOSIUM: Change compliance to change the game in PAD treatment

supported by Shockwave Medical

Moderator:

Konstantinos Stavroulakis

Panelist:

Stefano Fazzini

Panelist:

Dominic Howard

Panelist:

Enrique Alejandre Lafont
1. 12:30 - 12:33
  
  Introduction
2. 12:33 - 12:43
  
  Is vessel compliance the key to successful outcomes in PAD?
3. 12:43 - 12:47
  
  Discussion
4. 12:47 - 12:57
  
  Preserving our options when treating calcified CLTI for future interventions
5. 12:57 - 13:01
  
  Discussion
6. 13:01 - 13:11
  
  How IVL fits ino my daily PAD practice: The St. Gallen experience
7. 13:11 - 13:15
  
  Discussion and conclusion
13:00 - 13:40, Scientific posters

Moderated poster round – Challenging cases: Carotid, Embolization, Iliac, Renal

Moderator:

Sigrid Nikol

Moderator:

Giovanni Federico Torsello
1. 13:00 - 13:05
  
  TCAR with intolerance to flow reversal
2. 13:05 - 13:10
  
  Combined Splenic artery aneurym coiling and UAE
3. 13:10 - 13:15
  
  Management of atypical Hemangioma with Kyphoplasty
4. 13:15 - 13:20
  
  Post PCNL refractory hematuria
5. 13:20 - 13:25
  
  Mid-term result of endovascular revascularisation of TASC D AIOD aortic occlusion in a low ejection fraction spiritual-guide man with Unibody Endograft
6. 13:25 - 13:30
  
  Acute complication in endovascular management of aortoiliac disease: Report of a challenging case with unexpected solutions and good results
7. 13:30 - 13:35
  
  A case of juvenile hypertension treated with percutaneous renal angioplasty for right renal artery stenosis
8. 13:35 - 13:40
  
  Acute embolic renal ischemia – Successful thromboaspiration with off-label devices
13:30 - 14:45, Main arena 1

Innovations, latest data, and new techniques in BTK-Interventions

Moderator:

Sahil Parikh

Moderator:

Marianne Brodmann

Panelist:

Miguel Montero

Panelist:

Torbjörn Fransson

Panelist:

Luis Mariano Palena

Panelist:

Edward Choke
1. 13:30 - 14:00
  
  Live case transmission from Leipzig
2. 14:00 - 14:05
  
  FIRST TIME DATA RELEASE: CRURAL DEB RCT (Ranger vs POBA in BTK)
3. 14:05 - 14:10
  
  FIRST TIME DATA RELEASE: MERLION trial: 24 months outcomes in tibial occlusive disease
4. 14:10 - 14:15
  
  FIRST TIME DATA RELEASE: Real world outcomes of Sirolimus coated balloon versus plain balloon angioplasty in CLTI patients: Data from HOPE prospective registry
5. 14:15 - 14:20
  
  FIRST TIME DATA RELEASE: DEEPER OUS trial: 6 months results with the bare temporary spur stent system in conjunction with paclitaxel coated balloons
6. 14:20 - 14:25
  
  Toba II BTK: 36-month results
7. 14:25 - 14:30
  
  Update on the LIFE-BTK RCT investigating a drug eluting bioresorbable scaffold below-the-knee
8. 14:30 - 14:35
  
  FIRST TIME DATA RELEASE: 1-year results of a new bioresorbable drug eluting scaffold (MOTIV) for BTK lesions in 60 patients
9. 14:35 - 14:40
  
  FIRST TIME DATA RELEASE: WARRIORS study: Wound-directed Angiosome RevasculaRIzation apprOach to patients with cRitical limb iSchemia, Prospective multicenter corelabo adjudicated study in 450 patients
10. 14:40 - 14:45
  
  Live case recap and discussion
13:30 - 15:30, Main arena 2

Endovascular procedures for the deep veins

Moderator:

Houman Jalaie

Moderator:

Ramon Varcoe

Panelist:

Raghu Kolluri

Panelist:

Oliver Schlager

Panelist:

Rick de Graaf
1. 13:30 - 13:55
  
  Live case transmission from Arnsberg
2. 13:55 - 14:02
  
  The classification of the chronic venous obstruction and its clinical impact
3. 14:02 - 14:09
  
  How to best grade a venous stenosis in the deep veins: Duplex, IVUS, Venography
4. 14:09 - 14:16
  
  Dedicated venous stents – a look at the technology and clinical studies
5. 14:16 - 14:23
  
  May Thurner stents
6. 14:23 - 14:30
  
  US Venous IDE Trials: Trends and disparities
7. 14:30 - 14:37
  
  Anticoagulation therapy for patients with venous stents +/- antiplatelet therapy
8. 14:37 - 14:44
  
  The INTERVENE trial: A novel percutaneous device to reconstruct the valves within the femoral veins in patients with DVI
9. 14:44 - 15:09
  
  Live case transmission from Arnsberg
10. 15:09 - 15:30
  
  Discussion
13:30 - 14:45, Speakers' corner

Challenging cases and complications: Miscellaneous/Carotid/Embolization

Moderator:

Jos van den Berg

Moderator:

Stephan Duda
1. 13:30 - 13:35
  
  Endovascular treatment of post-traumatic internal carotid artery pseudoaneurysm: a challenging case
2. 13:35 - 13:40
  
  Infected supra-aortic bypass reconstruction: About a nightmare
3. 13:40 - 13:45
  
  Sling ring, a type of Kommerell diverticulum approach
4. 13:45 - 13:50
  
  Angioplasty of left subclavian artery CTO lesion complicated with subclavian and LIMA dissection: A challenging case presentation
5. 13:50 - 13:55
  
  Retrieval of displaced ASD amplatzer septal occluder device through right femoral artery
6. 13:55 - 14:00
  
  Balloon-assisted coil and liquid embolization for large neck splenic artery aneurysm. Case report and literature review
7. 14:00 - 14:05
  
  Embolization of the thoracic duct utilizing only liquid embolic agent
8. 14:05 - 14:10
  
  Transjugular intrahepatic portosystemic shunting in the management of hepatic hydrothorax
9. 14:10 - 14:15
  
  Gastroduodenal artery stump pseudoaneurysm rupture following selective coil embolization repaired using covered stent placement
10. 14:15 - 14:20
  
  Dangerous biopsies
11. 14:20 - 14:25
  
  Giant AVM
12. 14:25 - 14:30
  
  Antineutrophil cytoplasmic antibody associated renal microaneurysms managed with renal embolization
13. 14:30 - 14:35
  
  Middle-term outcomes of snare piercing technique for chronic total occluded lower extremity disease
14. 14:35 - 14:45
  
  Discussion and conclusion
13:30 - 14:45, Technical forum

Scrub in with the expert: Complex iliac interventions

Moderator:

Sean Lyden

Moderator:

Nilo Mosquera

Panelist:

Hans Krankenberg

Panelist:

Chris Metzger

Panelist:

Giovanni Federico Torsello

Panelist:

Peter Goverde

Panelist:

Naoki Fujimura
1. 13:30 - 13:50
  
  Live case transmission from New York
2. 13:50 - 13:57
  
  FIRST TIME DATA RELEASE: COMFORT (COnteMporary strategy For aORToiliac intervention) registry
3. 13:57 - 14:03
  
  Balloon-expandable stainless steel or cobalt chromium stents for iliac artery revascularization Giovanni
4. 14:03 - 14:31
  
  Live case transmission from New York
5. 14:31 - 14:38
  
  Can Arteficial Intelligence play an important role in the therapy of aortoiliac occlusive disease: Preliminary results
6. 14:38 - 14:45
  
  Comparison of aortobifemoral bypass and endovascular treatment for chronic infrarenal abdominal aortic occlusion from the CHAOS (CHronic Abdominal Aortic Occlusion, ASian Multicenter) registry
14:45 - 16:00, Main arena 1

SYMPOSIUM: Global views: AcoArt DCB experience from different regions

supported by Acotec

Moderator:

Dierk Scheinert

Panelist:

Peter Schneider

Panelist:

Sahil Parikh

Panelist:

Thomas Zeller

Panelist:

Wei Guo
1. 14:45 - 15:15
  
  Live case transmission from Leipzig
2. 15:15 - 15:25
  
  Real world experience of AcoArt DCB in Leipzig
3. 15:25 - 15:35
  
  Preliminary data of DEBATE-BTK DUELL study
4. 15:35 - 15:45
  
  AcoArt DCB in below-the-knee – Chinese real world data
5. 15:45 - 16:00
  
  Discussion and conclusion
14:45 - 15:30, Speakers' corner

CICE@LINC Brazilian techniques and technologies for endovascular aortic aneurysm intervention

Moderator:

Armando Lobato

Panelist:

Giovanni Torsello
1. 14:45 - 14:53
  
  The Brazilian Apolo – Nano repositionable endograft: A new tool for endovascular treatment of complex aortic aneurysms
2. 14:54 - 15:02
  
  Initial Experience with Apolo – Nano in complex aortic interventions: 9-months results
3. 15:03 - 15:11
  
  Endovascular treatment of complex aortic aneurysms with customized Brazilian endoprosthesis in the public health system
4. 15:12 - 15:20
  
  Lobato technique for the endovascular treatment of complicated dissections of the thoracic aorta and common iliac artery
5. 15:20 - 15:30
  
  Panel discussion
14:45 - 15:15, Technical forum

FOCUS SESSION: Complex AIOD – open, endo or hybrid? That’s the question

supported by Getinge

Moderator:

Koen Deloose
1. 14:45 - 15:15
  
  Recorded case presentation from AZ Sint Blasius Dendermonde, Belgium – Join the discussion on what’s the best solution during each step of this complex procedure
15:15 - 16:45, Technical forum

Transcatheter arterialization of deep veins (TADV) for patients with CLTI

Moderator:

Peter Schneider

Panelist:

Roberto Ferraresi

Panelist:

Miguel Montero

Panelist:

Steven Kum

Panelist:

Daniel van den Heuvel
1. 15:15 - 15:22
  
  Deep venous arterialization – how does it work? Latest insights
2. 15:22 - 15:27
  
  Current evidence on transcatheter arterialization of deep veins: PROMISE II 6-month sub analysis
3. 15:27 - 15:32
  
  Current evidence on transcatheter arterialization of deep veins: PI/ALPS – deep dive into data
4. 15:32 - 15:37
  
  Current evidence on transcatheter arterialization of deep veins: PROMISE II/CLariTI analysis
5. 15:37 - 15:43
  
  Discussion
6. 15:43 - 15:53
  
  Recorded case presentation: From PROMISE II
7. 15:53 - 15:58
  
  Discussion
8. 15:58 - 16:03
  
  Patient identification and assessment: TADV patient selection
9. 16:03 - 16:08
  
  Patient identification and assessment: TADV patient pre/post ultrasound evaluation
10. 16:08 - 16:13
  
  Patient identification and assessment: TADV overview with latest LimFlow devices
11. 16:13 - 16:18
  
  Patient identification and assessment: TADV pressure wire analysis
12. 16:18 - 16:23
  
  Discussion
13. 16:23 - 16:28
  
  Post procedure best practices: Wound care case example and best practices
14. 16:28 - 16:45
  
  Discussion
15:30 - 16:15, Main arena 2

SYMPOSIUM: Hemodialysis access creation and maintenance: Implications of long-term data on patient outcomes

supported by Medtronic

Moderator:

Fabrizzio Fanelli

Panelist:

Robert Shahverdyan

Panelist:

Matteo Tozzi
1. 15:30 - 15:35
  
  Welcome & introductions
2. 15:35 - 15:43
  
  Overview of long-term evidence in arteriovenous fistula creation and maintenance
3. 15:43 - 15:51
  
  Case discussion: EndoAVF creation from mapping to cannulation
4. 15:51 - 15:59
  
  Treating challenging lesions: My algorithm for Cephalic Arch Stenosis
5. 15:59 - 16:14
  
  Discussion & questions
6. 16:14 - 16:15
  
  Closing remarks
15:30 - 16:45, Speakers' corner

Update on innovations, clinical trials and new data – treatment of femoropopliteal PAD I – part I

Moderator:

Ralf Langhoff

Moderator:

Lieven Maene
1. 15:30 - 15:35
  
  2-year clinical outcome of the Eluvia drug-eluting stent for femoropopliteal lesions: A prospective multicenter K-ELUVIA registry
2. 15:35 - 15:40
  
  CVT-SFA-trial: First report of 6 months results using a new Everolimus coated balloon technology
3. 15:40 - 15:45
  
  Performance of a novel Sirolimus eluting balloon in peripheral arterial disease: Insights from the SUCCESS PTA study
4. 15:45 - 15:50
  
  Safety, efficacy and clinical implications of drug-coated devices in the endovascular treatment of femoropopliteal lesions
5. 15:50 - 15:55
  
  Comparative 2-year clinical outcomes of paclitaxel-eluting stent and drug-coated balloons in large vessels of femoropopliteal artery lesions
6. 15:55 - 16:00
  
  Safety of a dual drug sirolimus and ptx coated balloon (Sirplux™ DCB) vs a commercially available PTX DCB in swine coronary arteries
7. 16:00 - 16:05
  
  2-year outcome among the bare metal stent, atherectomy combined with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion
8. 16:05 - 16:10
  
  BIOPACT RCT – subgroup analysis to assess for heterogeneity of clinical endpoints, for patients treated with Passeo-18 Lux DCB vs IN.PACT Admiral DCB for femoropopliteal lesions
9. 16:10 - 16:15
  
  Resorbable Repair Device (RRD) for coverage of flow limiting dissections after DCB angioplasty
10. 16:15 - 16:20
  
  Vascular effects through Sirolimus vs. Paclitaxel DCB treatment in symptomatic peripheral artery disease – the Limus FLOW investigator-initiated randomized controlled trial
11. 16:20 - 16:25
  
  Analysis about the frequency of distal emboli due to three kinds of Paclitaxel-coated balloon in femoropopliteal artery using a laser doppler flowmetry
12. 16:25 - 16:30
  
  A case of virtual PQ bypass using double snare-piercing technique
13. 16:30 - 16:45
  
  Discussion and conclusion
16:00 - 18:00, Main arena 1

Evolving therapies and innovations for complex peripheral lesions – Focus on vessel preparation and durable outcomes

Moderator:

Thomas Zeller

Moderator:

Peter Soukas

Panelist:

Young-Guk Ko

Panelist:

Chris Metzger

Panelist:

Sabine Steiner

Panelist:

Erwin Blessing
1. 16:00 - 16:05
  
  No DCB class effect: How technology differences can influence performance
2. 16:05 - 16:30
  
  Live case transmission from Leipzig
3. 16:30 - 16:35
  
  DCB safety and effectiveness across real-world subgroups: Comprehensive 5-year outcomes of the IN.PACT global study
4. 16:35 - 16:40
  
  ILLUMENATE Global: 5-Year Results
5. 16:40 - 16:45
  
  Predictors of drug-coated balloon efficacy in femoropopliteal intervention: Insights from a patient-level pooled analysis Marianne
6. 16:45 - 16:50
  
  Vessel preparation prior to drug-coated balloons: Evidence from prospective and randomized trials
7. 16:50 - 16:55
  
  How I use directional atherectomy: Tips for successful vessel preparation
8. 16:55 - 17:00
  
  FIRST TIME DATA RELEASE: BEST SFA-RCT comparing balloon-based and stent-based reconstruction and drug delivery strategies in complex femoropopliteal obstructions
9. 17:00 - 17:30
  
  Live case transmission from New York
10. 17:30 - 17:35
  
  Cost-effectiveness of drug-coated balloons for femoropopliteal chronic limb-threatening ischemia
11. 17:35 - 17:40
  
  Update from the Münster registry of Eluvia in long lesions
12. 17:40 - 17:45
  
  MIMICS-3D: Compelling 3-year results for BioMimics 3D in complex lesions
13. 17:45 - 17:50
  
  Outcomes and evidence of the covered self-expandable stents for the treatment of critical limb ischemia patients
14. 17:50 - 18:00
  
  Live case recap and discussion
16:15 - 18:00, Main arena 2

Scrub in with the experts: Deep venous interventions – part II

Moderator:

Erin Murphy

Panelist:

Houman Jalaie

Panelist:

Tobias Hirsch

Panelist:

Oliver Schlager

Panelist:

Michael Piorkowski
1. 16:15 - 16:30
  
  Live case transmission from Galway
2. 16:30 - 16:37
  
  FLASH PRESENTATION: Patency definitions in the venous space: What is the impact?
3. 16:37 - 16:44
  
  FLASH PRESENTATION: Final update on VERNACULAR study and current update on Arnsberg Venovo registry
4. 16:44 - 16:59
  
  Live case transmission from Arnsberg
5. 16:59 - 17:06
  
  FLASH PRESENTATION: Update on BeYond venous PMCF study Michael
6. 17:06 - 17:29
  
  Live case transmission from Galway
7. 17:29 - 17:36
  
  FLASH PRESENTATION: Diagnostic and interventional approach to pelvic congestion syndrome
8. 17:36 - 17:43
  
  FLASH PRESENTATION: Endovascular managent of IVC occlusion syndrome
9. 17:43 - 18:00
  
  Live case transmission from Arnsberg
16:45 - 18:00, Technical forum

Scrub in with the expert: Innovative solutions for complex CTO`s

Moderator:

Gary Ansel

Moderator:

Daniela Branzan

Panelist:

Olaf Bakker

Panelist:

Konstantinos Stavroulakis

Panelist:

Robert Beasley
1. 16:45 - 17:10
  
  Live case transmission from Münster
2. 17:10 - 17:17
  
  A unique intraluminal crossing and subintimal reentry catheter for use in treating complex disease throughout the vascular system
3. 17:17 - 17:24
  
  Why BeBack is a game changer in crossing complex lesions
4. 17:24 - 18:00
  
  Live case transmission from Münster

Conference day 2

Wednesday, June 7th 2023

8:00 - 9:00, Main arena 1

CONNECT THE WORLD SESSION: CHINA – in collaboration with CEC – The state of the art in SFA treatment – insights from global experts

supported by Medtronic

Moderator:

Dierk Scheinert

Moderator:

Wei Guo

Co-Chair:

Zhong Chen

Co-Chair:

Weiguo Fu

Co-Chair:

Wei Guo

Panelist:

Eric Scott

Panelist:

Thomas Zeller
1. 08:00 - 08:05
  
  Welcome & introductions
2. 08:05 - 08:35
  
  Live case transmission from Beijing
3. 08:35 - 08:43
  
  Recanalized strategy of infrapopliteal arterial occlusive diseases: From Angiosome to Angiographosome
4. 08:43 - 08:51
  
  How to minimize trauma with vessel prep: My strategy in long occluded FPA lesions
5. 08:51 - 09:00
  
  Discussion & closing remarks
8:00 - 9:30, Main arena 2

Endovascular repair of iliac artery aneurysms – current techniques and results

Moderator:

Vicente Riambau

Moderator:

Armando Lobato

Panelist:

Reza Ghotbi

Panelist:

Fabio Verzini

Panelist:

Spiridon Botsios

Panelist:

Jorge Fernández Noya
1. 08:00 - 08:05
  
  10-year primary AAA outcomes from the ENGAGE OUS registry
2. 08:05 - 08:10
  
  Standard EVAR in patients with large luminal space is associated with increased risk of adverse events
3. 08:10 - 08:15
  
  Long term follow up data and durable outcomes with an infrarenal prosthesis
4. 08:15 - 08:20
  
  Multicentric European experience with the GORE IBE device for co-existing hypogastric aneurysms
5. 08:20 - 08:25
  
  Best approaches to maintain the internal iliac artery patency
6. 08:25 - 08:30
  
  5-year outcomes of iliac aneurysm approaches from the GREAT registry: IBE, Bell-Bottom, and coil/cover
7. 08:30 - 08:35
  
  Iliac branch devices after previous abdominal aortic aneurysm repair
8. 08:35 - 08:40
  
  How do iliac branching techniques influence the patient's quality of life, outcomes from the CARIBE study
9. 08:40 - 09:10
  
  Live case transmission from Paris
10. 09:10 - 09:15
  
  DCB utilization for erectile dysfunction
11. 09:15 - 09:30
  
  Live case wrap up and discussion
9:00 - 10:15, Main arena 1

SYMPOSIUM: See better to treat better: An image-guided therapy approach to reduce impact of recoil and dissections on acute and long-term outcomes

supported by Philips

Moderator:

Michael Lichtenberg

Moderator:

Masahiko Fujihara

Panelist:

Phil Puckridge
1. 09:00 - 09:25
  
  Live case transmission from Münster: See clearly – treat optimally masterclass
2. 09:25 - 09:35
  
  (Ultra) Sound advice: The evidence is clear – IVUS-based decision-making improves outcomes in lower limb revascularization
3. 09:35 - 09:45
  
  Debulking atherectomy in the peripheral arteries: Learning from 500 cases
4. 09:45 - 09:55
  
  Stenting vs scaffolding: Reducing chronic biological injury in post PTA dissection repair
5. 09:55 - 10:05
  
  A protocol for IVUS guided lower limb revascularisation with case examples
6. 10:05 - 10:15
  
  Discussion and conclusion
9:00 - 10:15, Speakers' corner

Update on innovations, clinical trials and new data – EVAR/TEVAR I

Moderator:

Piotr Kasprzak

Moderator:

Martin Malina
1. 09:00 - 09:05
  
  Role of contrast enhanced ultrasound in the follow-up of endovascular abdominal aortic aneurysm repair
2. 09:05 - 09:10
  
  The importance of the hypogastric artery preservation during treatment for aortoiliac aneurysms
3. 09:10 - 09:15
  
  Percutaneous large bore arterial access – is there scope for day-case EVAR
4. 09:15 - 09:20
  
  30-d outcomes after endovascular repair of ruptured abdominal aortic aneurysm: A systematic review and meta-analysis
5. 09:20 - 09:25
  
  3-years results of a prospective study on the E-liac branch device system in patients with common iliac artery aneurysms – the PLIANT study
6. 09:25 - 09:30
  
  Pararenal aortic thrombous in patients undergoing aortic aneurysm repair with chimney technique
7. 09:30 - 09:35
  
  Aortic arch surgery at Almazov center: Modern technologies and looking to the future
8. 09:35 - 09:40
  
  Conformable infrarenal endograft in abdominal aortic aneurysm treatment: A feaseble solution in case of hostile aortic neck. A single center experience
9. 09:40 - 09:45
  
  In-vitro and in-silico haemodynamic analyses of a novel embedded iliac branch device
10. 09:45 - 09:50
  
  Single-center results of the Gore Excluder Conformable Endoprosthesis with active control system in endovascular aneurysm repair
11. 09:50 - 09:55
  
  Quantitative flow evaluation for left subclavian artery during thoracic endovascular aortic repair
12. 09:55 - 10:00
  
  Abdominal aortic aneurysm sac management with shape memory Polymer: early results from the AAA-SHAPE multicenter safety and feasibility trial
13. 10:00 - 10:05
  
  The role of location, length, and thickness of the intimal flap in the propagation of Stanford Type B aortic dissection based on ex-vivo porcine aorta models
14. 10:05 - 10:15
  
  Discussion and conclusion
9:00 - 10:30, Technical forum

Embolization therapies – part I – Tumor Ablation 2.0

Moderator:

Thomas J. Vogl

Panelist:

Maciej Pech

Panelist:

Philip Wiggermann

Panelist:

Kristina Ringe

Panelist:

Amer Malouhi
1. 09:00 - 09:07
  
  Basic principles: Thermoablation
2. 09:07 - 09:14
  
  Basic principles: Irreversible electroporation (IRE)
3. 09:14 - 09:21
  
  Basic principles: Kryoablation
4. 09:21 - 09:28
  
  Chest: Ablation of pulmonary lesions
5. 09:28 - 09:35
  
  Chest: Chemoembolization – new kid on the block?
6. 09:35 - 10:02
  
  Live case transmission from Jena
7. 10:02 - 10:09
  
  Kidney: Thermoablation
8. 10:09 - 10:16
  
  Kidney: Kryotherapy
9. 10:16 - 10:23
  
  Osteoidosteom: Thermoablation
10. 10:23 - 10:30
  
  Osteoidosteom: Kryoablation
9:30 - 10:45, Main arena 2

Endovascular solutions for obstructions of the aortic bifurcation

partially supported by W. L. Gore & Associates

Moderator:

Theodosios Bisdas

Panelist:

Michele Piazza

Panelist:

Michel Reijnen
1. 09:30 - 09:55
  
  Live case transmission from Leipzig
2. 09:55 - 10:02
  
  Methods to manage the aortic bifurcation in aorto-iliac occlusive disease
3. 10:02 - 10:09
  
  Self expanding and balloon expandable Gore endoprosthesis for endovascular repair of severe atherosclerotic aorto-iliac disease
4. 10:09 - 10:16
  
  Value of VBX balloon expandable covered stents in treating complex aorto-iliac occlusive disease: Advantages and considerations
5. 10:16 - 10:23
  
  Outcomes of self expandable covered stents for the treatment of external iliac occlusive disease
6. 10:23 - 10:30
  
  CTO in the external iliac artery; which treatment is preferable?
7. 10:30 - 10:45
  
  Live case wrap up and discussion
10:15 - 11:15, Main arena 1

FOCUS SESSION: Innovative solutions for calcified peripheral lesions

supported by Shockwave Medical

Moderator:

Marianne Brodmann

Moderator:

Chris Metzger

Panelist:

Michel Bosiers

Panelist:

Erwin Blessing
1. 10:15 - 10:25
  
  Shockwave IVL: The science of IVL and the importance of vessel compliance
2. 10:25 - 10:35
  
  Intravascular Lithotripsy: Sound science reinforced by sound data
3. 10:35 - 10:55
  
  Live case transmission from Leipzig
4. 10:55 - 11:15
  
  Discussion and conclusion
10:15 - 11:15, Speakers' corner

Update on innovations, clinical trials, and new data – treatment of aortoiliac PAD

Moderator:

Hans Krankenberg

Moderator:

Koen Deloose
1. 10:15 - 10:20
  
  Technical consideration of endovascular treatment for aortoiliac occlusive disease based on a 10-year Songklanagarind hospital experience
2. 10:20 - 10:25
  
  Safety, feasibility, and efficacy of micronet-covered stent use in consecutive increased-risk iliac stenotic lesions to optimize acute angiographic result and guard effective flow: A multi-center, multi-specialty study (FLOWGUARD-ILIAC, NCT04461717)
3. 10:25 - 10:30
  
  Intravascular lithotripsy for the treatment of iliac artery calcification: Results from the Disrupt PAD III observational study
4. 10:30 - 10:35
  
  Clinical performance comparison between covered and bare metal stents in the treatment of TASC A-D aorto Iliac lesions
5. 10:35 - 10:40
  
  Endovascular treatment vs hybrid repair for iliofemoral occlusive disease: A prospective randomized trial
6. 10:40 - 10:45
  
  Novel extra-anatomical course for infected aorto-iliac axis: Paracolic gutter routing
7. 10:45 - 10:50
  
  Challenging case of trans-collateral retrograde approach for internal iliac artery occlusion
8. 10:50 - 11:15
  
  Discussion and conclusion
10:30 - 11:10, Scientific posters

Moderated poster round – Original research: BTK, CLI, PVD, SFA

Moderator:

Ralf Langhoff

Moderator:

Francesco Liistro
1. 10:30 - 10:35
  
  Post-operative bleeding events following lower extremity revascularisation is associated with increased platelet inhibition identified by thromboelastography with platelet mapping
2. 10:35 - 10:40
  
  Outcome of catheter directed thrombolysis for popliteal or infrapopliteal acute arterial occlusion
3. 10:40 - 10:45
  
  Single tibial artery angioplasty
4. 10:45 - 10:50
  
  Laxative prescription and number of drugs are useful for prognostic stratification in LEAD patient
5. 10:50 - 10:55
  
  Vascular closure devices in the endovascular treatment of aortic coarctation
6. 10:55 - 11:00
  
  Underutilization of guideline-recommended therapy in patients 80 years and older with peripheral artery diseases
7. 11:00 - 11:05
  
  Lipoprotein (a) as a potential risk factor for thrombosis in patients with superficial femoral artery disease
8. 11:05 - 11:10
  
  A comparison of pharmaco-mechanical thrombolysis and catheter-directed thrombosis for treatment of thromboembolic occlusion of lower limb – an observational case-control study
10:30 - 11:30, Technical forum

Interventions for maintenance of AV-access

Moderator:

Matteo Tozzi

Moderator:

Panagiotis Kitrou

Panelist:

Dimitrios Karnabatidis

Panelist:

Shimon Aronhime

Panelist:

Scott Trerotola
1. 10:30 - 10:37
  
  Recent publications in vascular access maintenance
2. 10:37 - 10:44
  
  IN.PACT AV access trial outcomes to date
3. 10:44 - 10:51
  
  Patient and procedural variables of AV-access treatment with DCB
4. 10:51 - 10:58
  
  Venous stents for central venous disease in hemodialysis patients – a comparative single center experience
5. 10:58 - 11:05
  
  Cephalic arch outcomes with covered stents
6. 11:05 - 11:12
  
  Prolonging patency following salvage of thrombosed AV-access
7. 11:12 - 11:19
  
  FIRST TIME DATA RELEASE: Interim look at the Lutonix AV Post Approval study
8. 11:19 - 11:30
  
  Panel discussion
10:45 - 12:30, Main arena 2

Infrarenal EVAR: Latest data, remaining challenges and open questions

Moderator:

Giovanni Torsello

Moderator:

Michel Reijnen

Panelist:

Hence Verhagen

Panelist:

Daniela Branzan

Panelist:

Konstantinos Donas
1. 10:45 - 10:50
  
  Focus on aneurysm sac regression: ADVANCE RCT design: A new AAA head-to-head study evaluating the sac regression outcomes two different endografts
2. 10:50 - 10:55
  
  Focus on aneurysm sac regression: Retrospective data analysis on sac regression with low permeability excluder
3. 10:55 - 11:00
  
  Focus on aneurysm sac regression: Active sac management: The missing link of EVAR?
4. 11:00 - 11:05
  
  Focus on aneurysm sac regression: AAA sac behavior following pre-emptive embolization of side branches for EVAR
5. 11:05 - 11:15
  
  Panel discussion
6. 11:15 - 11:45
  
  Live case transmission from Münster
7. 11:45 - 11:50
  
  Focus on acute EVAR: EVAR is currently the best treatment for ruptured AAAs despite randomized trials showing otherwise
8. 11:50 - 11:55
  
  Focus on acute EVAR: EVAR for ruptured AAA – How to do it?
9. 11:55 - 12:00
  
  Focus on acute EVAR: Emergency EVAR for ruptured Abdominal Aortic Aneurysms: Our first experience and challenges
10. 12:00 - 12:05
  
  Focus on acute EVAR: Urgent treatment of thoracoabdominal and pararenal pathologies using physician modified stent-grafts based on 3D printed aortic models
11. 12:05 - 12:10
  
  Focus on acute EVAR: The role of ChEVAR for acute EVAR
12. 12:10 - 12:15
  
  Focus on acute EVAR: Iliac artery – ureteral fistula: open or endovascular treatment
13. 12:15 - 12:20
  
  Focus on acute EVAR: Status update on AORTYX Patch: A new endovascular approach for focal aortic lesions
14. 12:20 - 12:25
  
  Panel discussion
15. 12:25 - 12:30
  
  Focus on acute EVAR: Many mycotic aneurysms and infected grafts benefit from non-radical surgery with better primary and late results
11:15 - 12:30, Main arena 1

SYMPOSIUM: Live case and discussion with global experts: Preserving future treatment options in long femoropopliteal lesions

supported by Medtronic

Moderator:

Dierk Scheinert

Panelist:

Yoshimitsu Soga

Panelist:

Thomas Zeller
1. 11:15 - 11:20
  
  Welcome & introduction
2. 11:20 - 11:25
  
  Introduce live case and Dr. Schmidt
3. 11:25 - 11:55
  
  Live case transmission from Leipzig
4. 11:55 - 12:05
  
  FLASH PRESENTATION: Factors associated with drug-coated balloon patency in femoropopliteal lesions
5. 12:05 - 12:15
  
  FLASH PRESENTATION: What is my endovascular approach for optimal lumen gain, and why
6. 12:15 - 12:25
  
  Discussion & questions
7. 12:25 - 12:30
  
  Closing remarks
11:15 - 12:30, Speakers' corner

Update on innovations, clinical trials, and new data – treatment of CLTI

Moderator:

Francesco Liistro

Moderator:

Raghu Kolluri
1. 11:15 - 11:20
  
  Direct vs indirect revascularization in the treatment of ischemic heel: A prospective comparative study
2. 11:20 - 11:25
  
  Combined stromal vascular fraction therapy and endovascular revascularization for diabetic foot salvage. A Tunisian experience
3. 11:25 - 11:30
  
  Ultra-low dose contrast angiography and revascularization in patients with CLTI and chronic renal impairment
4. 11:30 - 11:35
  
  Angiogenic factors changes after endovascular revascularization of lower limb arteries in patients with diabetic foot syndrome
5. 11:35 - 11:40
  
  Successful application of extracorporeal circulation compression perfusion in the treatment of diabetic foot: A retrospective cross-sectional study
6. 11:40 - 11:45
  
  Wharton’s jelly mesenchymal stem/stromal cells in no-option critical limb ischemia – the CIRCULATE N-O CLI pilot study
7. 11:45 - 11:50
  
  The impact of revascularization on the change in cultivated bacteriota in ulcerations in neuropathic-ischemic diabetic foot syndrome
8. 11:50 - 11:55
  
  Improvement opportunities in chronic limb threatening ischemia – experience of a Latin American center
9. 11:55 - 12:30
  
  Discussion and conclusion
11:30 - 12:30, Technical forum

Percutaneous creation of AV-access: How far have we come?

Moderator:

Fabrizzio Fanelli

Moderator:

Scott Trerotola

Panelist:

Ounali Jaffer

Panelist:

Tobias Steinke
1. 11:30 - 11:37
  
  Focus on percutaneous AV-access creation: Recent publications in vascular access creation
2. 11:37 - 11:44
  
  Focus on percutaneous AV-access creation: Recent updates from the Hamburg registry
3. 11:44 - 11:51
  
  Focus on percutaneous AV-access creation: Initial experience and lessons learned with endoAVF: A multi-disciplinary approach
4. 11:51 - 11:58
  
  Focus on percutaneous AV-access creation: Is endoAVF economical? A surgeon’s experience
5. 11:58 - 12:05
  
  Focus on percutaneous AV-access creation: Key steps to setting up an EndoAVF practice
6. 12:05 - 12:12
  
  Focus on percutaneous AV-access creation: EndoAVF creation: Training needs from creation to cannulation
7. 12:12 - 12:30
  
  Panel discussion
12:30 - 13:15, Main arena 1

LUNCH SYMPOSIUM: Versatility without compromise: The PAD workflow of the future with a new all-in-one solution

supported by BIOTRONIK

Moderator:

Koen Deloose

Panelist:

Ralf Langhoff

Panelist:

Luis Mariano Palena
1. 12:30 - 12:40
  
  A new multifunctional solution for PAD
2. 12:40 - 12:48
  
  Results of a real-world user evaluation of the Oscar catheter
3. 12:48 - 12:56
  
  Oscar for simplifying SFA lesions
4. 12:56 - 13:04
  
  Oscar for below-the-knee disease
5. 13:04 - 13:15
  
  Questions, discussions, and conclusion
12:30 - 13:15, Main arena 2

LUNCH SYMPOSIUM: Which is the best stenting approach in the iliac artery?

supported by iVascular

Moderator:

Vicente Riambau

Panelist:

August Ysa

Panelist:

Thomas Zeller

Panelist:

Lieven Maene
1. 12:30 - 12:40
  
  Complex iliac treatment with a new generation covered stent
2. 12:40 - 12:50
  
  Treating iliac stenosis with a BX covered stent. The iliCo study
3. 12:50 - 13:00
  
  Is there still a role for BMS in the iliac artery?
4. 13:00 - 13:15
  
  Discussion and conclusion
12:30 - 13:30, Speakers' corner

PAIRS@LINC: Embolization techniques

Speaker:

Ayman Al Sibaie

Moderator:

Maciej Pech
1. 12:30 - 12:37
  
  Bronchial embolization for treatment of hemoptysis
2. 12:37 - 12:44
  
  Complications of the UFE in the UAE
3. 12:44 - 12:51
  
  Prostatic artery embolization: Updates and technique optimization
4. 12:51 - 12:58
  
  Hemorrhoids embolization: What you need to know
5. 12:58 - 13:05
  
  Emergency embolization tool kit: Be always prepared
6. 13:05 - 13:12
  
  Management of visceral aneurysms
7. 13:12 - 13:19
  
  Embolization of iatrogenic injuries
8. 13:19 - 13:30
  
  Discussion and conclusion
12:35 - 13:20, Technical forum

LUNCH SYMPOSIUM: How does a lytic-free, bloodless approach advance the treatment of venous thromboembolism?

supported by Inari Medical

Panelist:

Steven Abramowitz

Panelist:

Michael Lichtenberg

Panelist:

Michael Piorkowski
1. 12:35 - 12:40
  
  Introduction
2. 12:40 - 12:50
  
  How do DEFIANCE and CLOUT answer critical questions about the management of DVT?
3. 12:50 - 13:00
  
  Why doesn’t existing clinical data initiate a change in the current DVT treatment guidelines
4. 13:00 - 13:10
  
  FLowTriever system as the first-choice treatment of acute PE patients
5. 13:10 - 13:20
  
  Q&A and closing
13:30 - 14:45, Main arena 1

SYMPOSIUM: Treating challenging anatomies and the impact on clinical outcomes

supported by W. L. Gore & Associates

Moderator:

Michel Reijnen

Panelist:

Martin Austermann

Panelist:

Jan Heyligers
1. 13:30 - 13:40
  
  Does conformability have an impact on the outcomes of endovascular repair of Type B aortic dissection
2. 13:40 - 13:50
  
  Does conformability have an impact on the outcomes of endovascular repair of AAA with angulated infrarenal necks
3. 13:50 - 14:00
  
  Does conformability have an impact on the outcomes of endovascular repair of Iliac limbs performance
4. 14:00 - 14:10
  
  Importance of conformability. Real world evidence from a complex subgroup of the EXPAND registry
5. 14:10 - 14:20
  
  Influencing procedure success, does the choice of stent matter in complex AIOD treatment?
6. 14:20 - 14:30
  
  Approaching the challenge of the complex SFA lesion – a data driven approach
7. 14:30 - 14:45
  
  Discussion and conclusion
13:30 - 14:45, Main arena 2

SYMPOSIUM: Sirolimus coated balloon: Is it an ideal choice for the treatment of ED and dysfunctional AVF & AVG?

supported by Concept Medical

Moderator:

Aravinda Nanjundappa

Moderator:

Giuseppe Sangiorgi

Panelist:

Edward Choke

Panelist:

Aloke Finn

Panelist:

Tang Tjun Yip

Panelist:

Nattawut Puangpunngam

Panelist:

Wuttichai Saengprakai
1. 13:30 - 13:32
  
  Introduction and session objectives
2. 13:32 - 13:40
  
  Advantages of Sirolimus over Paclitaxel for treatment of AVF and AVG: A deep dive into Sirolimus coated balloons
3. 13:40 - 13:44
  
  Discussion
4. 13:44 - 13:52
  
  The MATILDA story – a look back over the last 3 years
5. 13:52 - 13:56
  
  Discussion
6. 13:56 - 14:08
  
  Updates on the utility of sirolimus-coated balloon in dysfunctional arteriovenous accesses
7. 14:08 - 14:12
  
  Discussion
8. 14:12 - 14:27
  
  Treatment of vasculogenic erectile dysfunction: Why DEB and not DES should be the ideal endovascular strategy
9. 14:27 - 14:31
  
  Discussion
10. 14:31 - 14:37
  
  MagicTouch AVF – US FDA Study Design
11. 14:37 - 14:45
  
  Discussion and conclusion
13:30 - 14:25, Scientific posters

Moderated poster round – Challenging cases: EVAR, Supraaortic, TEVAR

Moderator:

Giovanni Torsello

Moderator:

Martin Malina
1. 13:30 - 13:35
  
  Tools and techniques used to address difficult to catheterize visceral branches during endovascular t-branch and thoracic and abdominal endovascular graft repair
2. 13:35 - 13:40
  
  Two thoracoabdominal aneurysms, one ruptured, and the other in imminent rupture, urgent and emergent endovascular management treated with T-branch multigraft stent grafts
3. 13:40 - 13:45
  
  Alternativ access options for tevar in case of complications: Case report of posttraumatic aneurysm treatment
4. 13:45 - 13:50
  
  How to manage challenging target visceral vessel cannulation in complex aortic procedures
5. 13:50 - 13:55
  
  Interventional repair of a vascular aneurysm in a patient with Marfan syndrome
6. 13:55 - 14:00
  
  Alternatives for endovascular treatment of patients with abdominal aortic aneurysm (AAA) and hostile anatomy: Effective application of a technique in two cases
7. 14:00 - 14:05
  
  Management of failed endovascular repair of endoleak after EVAR
8. 14:05 - 14:10
  
  Subclavian pseudoaneurysm presenting with hemoptysis
9. 14:10 - 14:15
  
  A case of EVT for acute brachial arterial thrombosis
10. 14:15 - 14:20
  
  Endovascular treatment of an iatrogenic extracranial carotid-jugular arteriovenous fistula
11. 14:20 - 14:25
  
  Successful TEVAR in unstable thoracic aortic aneurysm (impending rupture) with intramural hematoma presenting with acute ischemic stroke
13:30 - 14:30, Speakers' corner

Update on innovations, clinical trials and new data – BTK interventions

Moderator:

Marianne Brodmann

Moderator:

Luis Mariano Palena
1. 13:30 - 13:35
  
  Treatment of stenotic lesions below-the-knee with an OCT-guided atherectomy catheter
2. 13:35 - 13:40
  
  Long term outcomes of a novel Sirolimus drug eluting balloon in the treatment of complex below-the-knee disease in patients with chronic limb threatening ischemia – 24 months results from the PRESTIGE study
3. 13:40 - 13:45
  
  First report of the 12 months results from the PRISTINE registry: role of sustained drug release with a Sirolimus Eluting Balloon in the treatment of complex infrainguinal atherosclerotic disease in patients with chronic limb threatening ischemia
4. 13:45 - 13:50
  
  The new therapeutic horizons with a novel sirolimus eluting balloon technology in endovascular treatment of critical limb ischaemia CLI
5. 13:50 - 13:55
  
  SELUTION4BTK – a randomized clinical trial evaluating SELUTION SLR sirolimus-eluting balloon in the treatment of below-the-knee lesions in patients with chronic limb threatening ischemia
6. 13:55 - 14:00
  
  Usefulness of a pressure sensing microcatheter during endovascular therapy for below-the-knee lesions
7. 14:00 - 14:05
  
  A comparison of the optimal vessel sizing and calcification between intravascular imaging and angiography in peripheral arterial disease: A correlation analysis with interrater agreement
8. 14:05 - 14:10
  
  The Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee trial: 36-month results
9. 14:10 - 14:15
  
  Retrograde balloon-assisted approach to prevent distal embolisation during complex recanalisation procedures
10. 14:15 - 14:20
  
  First experience with a Sirolimus coated balloon* for peripheral vessels combined in various techniques of closed and open endovascular procedures in 90 cases
11. 14:20 - 14:25
  
  The BEnefit of LONGitudinal micro-incisions prior to Paclitaxel-coated balloon angioplasty (BELONG) study in patients with lower extremity artery stenosis: Contemporary comparison of clinical outcomes at 12 months
12. 14:25 - 14:30
  
  Discussion and conclusion
13:30 - 14:45, Technical forum

Embolization therapies – part II – Established and evolving indications and techniques

Moderator:

Fabrizzio Fanelli

Moderator:

Maciej Pech

Panelist:

Anna Maria Ierardi

Panelist:

Romaric Loffroy

Panelist:

Federico Collettini
1. 13:30 - 13:37
  
  Treating traumas: Plugs, coils, or liquids?
2. 13:37 - 13:44
  
  Utilization of liquid embolics and coils in pelvic venous disorder
3. 13:44 - 13:51
  
  Pelvic venous disorder: Selecting the right patient
4. 13:51 - 13:58
  
  Liquid embolic treatment of Type II endoleaks by direct puncture
5. 13:58 - 14:23
  
  Live case transmission from Jena
6. 14:23 - 14:30
  
  Latest techniques and results of prostate adenoma embolization therapy
7. 14:30 - 14:37
  
  Irreversible electroporation (IRE)
8. 14:37 - 14:45
  
  Panel discussion
14:30 - 15:30, Speakers' corner

Update on innovations, clinical trials and new data – treatment of femoropopliteal PAD I – part II

Moderator:

Ralf Langhoff

Moderator:

Yann Gouëffic
1. 14:30 - 14:35
  
  Clinical impact of additional Cilostazol treatment on restenosis risk following Heparin-bonded stent graft implantation: Sub-analysis from the Viabahn stent-graft placement for femoropopliteal diseases requiring endovascular therapy (VANQUISH) study
2. 14:35 - 14:40
  
  Intravascular Lithotripsy for the treatment of common femoral artery calcification: Results from the disrupt PAD III observational study
3. 14:40 - 14:45
  
  3 years comparable clinical outcome for Trans-Atlantic Inter-Society Consensus (TASC) D femoropopliteal occlusion: Endovascular vs bypass surgery
4. 14:45 - 14:50
  
  Midterm results of the Supera stent for the treatment of multi-level occlusive atherosclerotic artery disease
5. 14:50 - 14:55
  
  The influence of diabetes, lesion length, calcification, and bailout stenting on CD-TLR, safety, patency, ABI and RCC in the BIOPACT RCT trial
6. 14:55 - 15:00
  
  Endovascular and surgical revascularization techniques in long femoropopliteal lesions – 2-year results of a patient-level meta analysis
7. 15:00 - 15:05
  
  Comparing 12-months results of the CE and IDE studies and the PATHFINDER post-market registry evaluating the safety and efficacy of the Auryon laser atherectomy system
8. 15:05 - 15:10
  
  The 1-year result of PRESTO for TASC D femoropopliteal artery lesion: Single centre experience in Hong Kong
9. 15:10 - 15:30
  
  Discussion and conclusion
14:45 - 16:00, Main arena 1

SYMPOSIUM: When science meets practice – quality outcomes for your PAD patients

supported by BD

Moderator:

Thomas Zeller

Panelist:

Michael Lichtenberg

Panelist:

Christos Rammos

Panelist:

Elias Noory
1. 14:45 - 15:10
  
  Live case transmission from Leipzig
2. 15:10 - 15:19
  
  ULTRASCORE™ focused force PTA balloon angioplasty for CLI patients with below-the-knee vessel disease – 6 months provisional results
3. 15:19 - 15:27
  
  The science behind Atherothrombectomy – SAVioR IVUS study
4. 15:27 - 15:36
  
  Recorded case presentation – subacute in stent reocclusion of femeropopliteal artery
5. 15:36 - 15:45
  
  Challenges in treating mixed morphology SFA lesions – my strategy for success
6. 15:45 - 16:00
  
  Discussion and conclusion
14:45 - 15:45, Main arena 2

Fireside chat: Imaging in endovascular procedures: Which improvements will change the game?

partially supported by Siemens Healthineers

Moderator:

Giovanni Torsello

Panelist:

Tilo Kölbel

Panelist:

Maani Hakimi

Panelist:

Andrej Schmidt
1. 14:45 - 15:05
  
  Discussion
2. 15:05 - 15:10
  
  Radiation safety in complex aortic repair: Do’s and Don’ts
3. 15:10 - 15:15
  
  Meticulous planning leads to a dose-conscious workflow with the ARTIS pheno
4. 15:15 - 15:20
  
  Application of ultra-low dose protocols in fenestrated Aortic Arch Reconstruction
5. 15:20 - 15:25
  
  Influence of fusion imaging with Cydar on radiation exposure in EVAR
6. 15:25 - 15:30
  
  Case reviews examples performed with FORS and new 3D Hub technology, showing increased visualization and radiation reduction
7. 15:30 - 15:35
  
  FORS technology – experience and clinical data so far
8. 15:35 - 15:40
  
  30 years’ experience using CO2 as a contrast medium in vascular procedures
9. 15:40 - 15:45
  
  Conclusion
14:45 - 16:00, Technical forum

VIVA@LINC session: Deep venous dilemmas

Moderator:

Raghu Kolluri

Panelist:

Sean Lyden

Panelist:

Chris Metzger

Panelist:

Peter Schneider

Panelist:

Kush Desai
1. 14:45 - 15:10
  
  Live case transmission from Colorado
2. 15:10 - 15:15
  
  FLASH PRESENTATIONS: Technical tips for iliac vein stenting
3. 15:15 - 15:20
  
  FLASH PRESENTATIONS: Thrombectomy for DVT: When to treat and how to treat
4. 15:20 - 15:50
  
  Live case transmission from Colorado
5. 15:50 - 15:55
  
  FLASH PRESENTATIONS: Management of combined arterial and venous insufficiency
6. 15:55 - 16:00
  
  FLASH PRESENTATIONS: Crossing techniques for iliocaval occlusion
15:30 - 16:45, Speakers' corner

Update on innovations, clinical trials and new data – Treatment of venous disease

Moderator:

Houman Jalaie

Moderator:

Oliver Schlager
1. 15:30 - 15:35
  
  Elevated post-intervention villalta scores predict late post-thrombotic syndrome development
2. 15:35 - 15:40
  
  Clinical outcomes of patients with PE undergoing EKOS-directed thrombolysis in Taiwan
3. 15:40 - 15:45
  
  The PEERLEESS randomized controlled trial design and rationale: Mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism
4. 15:45 - 15:50
  
  The impact of pelvic venous insufficiency (PVI) on quality of life of female patients
5. 15:50 - 15:55
  
  CLOTTriever all comers registry
6. 15:55 - 16:00
  
  Intelligent aspiration thrombectomy with a 12F catheter for the treatment of acute iliofemoral deep vein thrombosis – eliminating thrombolytics
7. 16:00 - 16:05
  
  Venous aneurysm … does it differ? 25 years of experience in Egypt
8. 16:05 - 16:10
  
  3-year, real-world outcomes of venous stent placement for thrombotic and non-thrombotic indications in Spain
9. 16:10 - 16:15
  
  First experiences of combined proximal foam sclerotherapy and distal endovenous thermal laser ablation for recurrent varicose veins
10. 16:15 - 16:20
  
  Laser crossectomy vs anterior accessory vein laser ablation in treating anterior accessory vein reflux
11. 16:20 - 16:25
  
  Comparative study between endovascular coiling and laparoscopic excision of symptomatic ovarian vein
12. 16:25 - 16:45
  
  Discussion and conclusion
15:45 - 18:00, Main arena 2

Endovascular repair of thoracoabdominal aortic aneurysms

Moderator:

Tilo Kölbel

Panelist:

Daniela Branzan

Panelist:

Nikolaos Tsilimparis
1. 15:45 - 16:10
  
  Live case transmission from Paris
2. 16:10 - 16:15
  
  Role of physician modified endografts in thoracoabdominal aortic repair
3. 16:15 - 16:20
  
  Long-term outcomes of chimneys and Periscopes in TAAA-repair
4. 16:20 - 16:25
  
  Initial results of the GUARATTEE study investigating the G-Branch multiple branch stent graft for EVAR of TAAA
5. 16:25 - 16:30
  
  Outcomes of inner branches in complex thoracoabdominal repair
6. 16:30 - 16:35
  
  Preloaded off-the-shelf branched thoracoabdominal repair: Real world outcomes with the Artivion Enside
7. 16:35 - 16:45
  
  Panel discussion: Pros and Cons of new devices and techniques for endovascular treatment of TAAA
8. 16:45 - 17:10
  
  Live case transmission from Paris
9. 17:10 - 17:15
  
  The Münster strategy to avoid spinal cord ischemia during F/BEVAR
10. 17:15 - 17:20
  
  Spinal cord drainage for aortic repair: To drain or not, when and what are the risks
11. 17:20 - 17:25
  
  Interim analysis of Papa-Artis trial on MISACE
12. 17:25 - 17:30
  
  Evaluation of spinal cord blood supply after MISACE and EVAR of TAAA with hyperspectral imaging
13. 17:30 - 17:35
  
  Open branch in BEVAR of TAAA is still a valid concept to minimize paraplegia
14. 17:35 - 17:40
  
  Aortic coverage with CMD fenestrated vs. of-the-shelf branched devices and implications for the risk of spinal cord ischemia
15. 17:40 - 17:50
  
  Panel discussion: Best strategies for prevention of spinal cord ischemia
16. 17:50 - 17:55
  
  Open thoracoabdominal repair with the Thoracoflo Hybrid Graft: Early results
17. 17:55 - 18:00
  
  EVAR for ruptured TAAA
16:00 - 18:00, Main arena 1

VIVA@LINC: Progress in limb salvage: How do we prove which approach is best?

Moderator:

Peter Schneider

Moderator:

Marianne Brodmann

Panelist:

Sean Lyden

Panelist:

Raghu Kolluri

Panelist:

Chris Metzger

Panelist:

Tatsuya Nakama

Panelist:

Ramon Varcoe
1. 16:00 - 16:05
  
  Announcement of the winner of the Vascular Carreer Award 2023
2. 16:05 - 16:30
  
  Live case transmission from Colorado
3. 16:30 - 16:38
  
  How to interpret the results of BEST-CLI?
4. 16:38 - 16:46
  
  What are the right clinical trial endpoints for CLTI?
5. 16:46 - 16:54
  
  Wound healing assessment by core lab and what can it tell us?
6. 16:54 - 17:02
  
  The major ongoing need, what is the latest in managing calcification?
7. 17:02 - 17:10
  
  Latest data and concepts on deep venous arterialization in the US
8. 17:10 - 17:35
  
  Live case transmission from Leipzig
9. 17:35 - 18:00
  
  Discussion and conclusion
16:00 - 17:30, Technical forum

Embolization therapies III – Liver interventions

Moderator:

Thomas J. Vogl

Panelist:

Maciej Pech

Panelist:

Romaric Loffroy

Panelist:

Bernhard Gebauer
1. 16:00 - 16:07
  
  Liquid embolization of HCC
2. 16:07 - 16:14
  
  New indications for early TIPS
3. 16:14 - 16:39
  
  Live case transmission from Jena
4. 16:39 - 16:46
  
  Balloon-occluded retrograde transvenous obliteration
5. 16:46 - 16:53
  
  Transsplenic portal venous recanalisation
6. 16:53 - 17:00
  
  Transhepatic portal venous thrombectomy
7. 17:00 - 17:07
  
  GPX embolic device trial final results
8. 17:07 - 17:30
  
  Discussion and conclusion

Conference day 3

Thursday, June 8th 2023

8:00 - 10:00, Main arena 1

JET@LINC – Pioneering techniques and innovations for complex BTK disease

Moderator:

Tatsuya Nakama

Moderator:

Dierk Scheinert

Panelist:

Hiroyoshi Yokoi

Panelist:

Luis Mariano Palena

Panelist:

Steven Kum

Speaker:

Nattawut Puangpunngam
1. 08:00 - 08:30
  
  Live case transmission from Osaka
2. 08:30 - 08:35
  
  Guidewire escalation strategy for BTK CTO lesions
3. 08:35 - 08:40
  
  The best BTK crossing technique: Italian style
4. 08:40 - 08:45
  
  DEEPER OUS trial – vessel recoil substudy: Initial insights
5. 08:45 - 09:15
  
  Live case transmission from Abano Terme
6. 09:15 - 09:20
  
  FIRST TIME DATA RELEASE: Prestige – final 2-year results
7. 09:20 - 09:25
  
  Improving clinical outcome of infrapopliteal lesions with Cre8™ BTK: My personal experience
8. 09:25 - 09:30
  
  TOBA II BTK long lesion subanalysis
9. 09:30 - 09:35
  
  Update on the HEAL study using a microstent in BTK vessels
10. 09:35 - 09:40
  
  Below-the-knee DCBs – is Limus the holy grail in light of prior failed trials?
11. 09:40 - 09:45
  
  Update on the DEEPER LIMUS trial: Bare temporary spur stent system in conjunction with Sirolimus coated balloons
12. 09:45 - 09:50
  
  SWING trial: 12 months data with a novel Sirolimus DCB in a CLTI cohort
13. 09:50 - 09:55
  
  Update on the ACOART BTK RCT and the DEBATE BTK DUELL RCT
14. 09:55 - 10:00
  
  Discussion and conclusion
8:00 - 9:15, Main arena 2

New insights and evolving techniques for TEVAR of Type B aortic dissections

Moderator:

Vicente Riambau

Moderator:

Frans Moll

Panelist:

Hans Krankenberg

Panelist:

Hence Verhagen

Panelist:

Theodoros Kratimenos

Panelist:

Nikolaos Tsilimparis
1. 08:00 - 08:30
  
  Live case transmission from Münster
2. 08:30 - 08:35
  
  Optimal timing of thoracic endovascular aortic repair for uncomplicated Type B aortic dissection: A systematic review and meta-analysis
3. 08:35 - 08:40
  
  Male-female differences in acute Type B aortic dissection: The DisSEXion study
4. 08:40 - 08:45
  
  Prediction of the location at risk for intima dissection in TBAB
5. 08:45 - 08:50
  
  Endovascular repair of Type B aortic dissection importance of device design on outcomes
6. 08:50 - 08:55
  
  Durability can only be achieved through continous proximal seal: A decade of experience across multiple pathologies
7. 08:55 - 09:00
  
  The Munich Valsalva maneuver for cardiac output reduction during EVAR
8. 09:00 - 09:05
  
  Anticoagulation in dissection: Yes we definitively should do it!
9. 09:05 - 09:15
  
  Discussion and conclusion
9:00 - 9:45, Speakers' corner

Challenging cases and complications: Venous

Speaker:

Ayman Al Sibaie
1. 09:00 - 09:05
  
  Compression of the iliac veins caused by endovascular aortic aneurysm repai
2. 09:05 - 09:10
  
  IVC and Hepatic vein thrombosis in antiphospholipid syndrome
3. 09:10 - 09:15
  
  Off label use of atrial septal occluder in huge arterio-venous malformation with giant aneurysm
4. 09:15 - 09:20
  
  Right ovarian vein thrombosis and post partum left LE DVT
5. 09:20 - 09:25
  
  The “IRANI” procedure and its role in salvaging arteriovenous fistulas
6. 09:25 - 09:30
  
  Challenging cases with vascular access
7. 09:30 - 09:35
  
  Endovascular management of renal arteriovenous fistula and associated venous aneurysm
8. 09:35 - 09:45
  
  Discussion and conclusion
9:00 - 10:15, Technical forum

Scrub in with the expert: Carotid interventions

Moderator:

Ralf Langhoff

Moderator:

Arne Schwindt

Panelist:

Andrea Kahlberg

Panelist:

Gianmarco de Donato

Panelist:

Piotr Musialek

Panelist:

Eugenio Stabile
1. 09:00 - 09:25
  
  Live case transmission from Leipzig
2. 09:25 - 09:35
  
  Comparison of new-generation double-mesh carotid stents with old-generation devices
3. 09:35 - 09:45
  
  OCT-analysis of CAS cases – the benefit of Micro-NET
4. 09:45 - 10:15
  
  Live case transmission from Leipzig
9:15 - 10:00, Main arena 2

SYMPOSIUM: Standardization and evidence are essential to treating hostile AAA sealing zones

supported by Medtronic

Moderator:

Kyriakos Oikonomou

Panelist:

Jean-Paul de Vries

Panelist:

Michel Reijnen

Panelist:

Konstantinos Donas
1. 09:15 - 09:20
  
  Introduction
2. 09:20 - 09:28
  
  Sealing-zone concept & outcomes for ESAR in wide neck
3. 09:28 - 09:36
  
  Sac regression with ESAR – What do the data tell us
4. 09:36 - 09:44
  
  Outcomes for EnChEVAR in juxtarenal aneurysms
5. 09:44 - 09:52
  
  EnChEVAR patient selection and case planning
6. 09:52 - 10:00
  
  Discussion and conclusion
9:45 - 10:30, Speakers' corner

Challenging cases and complications: EVAR

Moderator:

Jean-Paul de Vries
1. 09:45 - 09:50
  
  A pyramid technique – a solution for a conical neck
2. 09:50 - 09:55
  
  A simultaneous balloon aortic valvuloplasty and endovascular abdominal aortic repair in a high-risk patient with a symptomatic abdominal aortic aneurysm
3. 09:55 - 10:00
  
  Emergent endovascular treatment of a rare case of streptococcus equi-related aortic rupture: Could a balloon expandable aortic stent graft represent a valid alternative device?
4. 10:00 - 10:05
  
  Type II endoleaks and their unique approaches
5. 10:05 - 10:10
  
  Open arteriotomy to manually deploy EVAR stent graft as a solution to avoid graft explantation after the delivery system sheath is completely disrupted during deployment
6. 10:10 - 10:30
  
  Discussion and conclusion
10:00 - 11:15, Main arena 1

SYMPOSIUM: Sirolimus coated balloon in PAD treatment: A step closer to the future

supported by Concept Medical

Moderator:

Dierk Scheinert

Moderator:

Brian DeRubertis

Panelist:

Sahil Parikh

Panelist:

Osamu Iida

Panelist:

Masahiko Fujihara

Panelist:

Stefano Barco

Panelist:

Tatsuya Nakama
1. 10:00 - 10:02
  
  Introduction and session objectives
2. 10:02 - 10:12
  
  36-month results from XTOSI and updates on the FUTURE RCTs
3. 10:12 - 10:22
  
  Updates on the SIRONA and LIMES RCT
4. 10:22 - 10:30
  
  SirPAD trial updates and case presentation
5. 10:30 - 10:38
  
  Update on the DEBATE-BTK DUELL
6. 10:38 - 10:46
  
  Real world outcomes of SCB in CLTI patients: Data from HOPE registry and the absence of slow-flow phenomenon with SCB in BTK diseases
7. 10:46 - 10:52
  
  IDE trials and future plans with the Sirolimus coated balloon
8. 10:52 - 11:15
  
  Discussion and conclusion
10:00 - 11:45, Main arena 2

Innovative approaches and new techniques for EVAR in challenging juxtarenal anatomies

Moderator:

Giovanni Torsello

Moderator:

Michel Reijnen

Panelist:

Reza Ghotbi

Panelist:

Konstantinos Donas

Panelist:

Stefano Fazzini
1. 10:00 - 10:05
  
  A meta-analysis of safety and efficacy of EVAR in aneurysm patients with angulated and hyperangulated neck
2. 10:05 - 10:15
  
  Recorded case presentation: Managing the angulated infra-renal aortic neck with standard devices
3. 10:15 - 10:40
  
  Live case transmission from Hamburg
4. 10:40 - 10:48
  
  Focus on endosuture/endoanchors: 3-year outcomes of endosuture aneurysm repair in patients with wide neck abdominal aneurysm form the ANCHOR registry and the HERCULES RCT design
5. 10:48 - 10:53
  
  Focus on endosuture/endoanchors: The effect of EndoAnchors on aneurysm sac regression for patients treated with infrarenal endovascular repair with hostile neck anatomies: A propensity scored analysis
6. 10:53 - 10:58
  
  Focus on endosuture/endoanchors: Endosuture aneurysm repair versus fenestrated aneurysm repair in patients with short-neck abdominal aortic aneurysm
7. 10:58 - 11:03
  
  Focus on endosuture/endoanchors: FIRST TIME DATA RELEASE: SOCRATES trial design: Physician-initiated trial comparing outcomes of ESAR and FEVAR in infrarenal short aortic neck aneurysms
8. 11:03 - 11:08
  
  Focus on Chimney technique: EnChevar is a new frontier addressing complex abdominal aneurysm disease
9. 11:08 - 11:13
  
  Focus on Chimney technique: EnChevar is a safe and effective procedure, if you do it right
10. 11:13 - 11:18
  
  Focus on Chimney technique: ENCHANT trial interim analysis: CHEVAR technique for juxtarenal aneurysms
11. 11:18 - 11:23
  
  Focus on new devices and techniques: Safety and efficacy of the WeFlow-JAAA stent graft system for juxtarenal AAA
12. 11:23 - 11:28
  
  Focus on new devices and techniques: Different case scenarios: Solution with funnel technique and SMFSG
13. 11:28 - 11:45
  
  Discussion and conclusion
10:15 - 11:00, Technical forum

Interwoven nitinol stent: Experts experience beyond the Superficial Femoral Artery

supported by Abbott Vascular

Moderator:

Koen Deloose

Panelist:

August Ysa

Panelist:

Ralf Langhoff
1. 10:15 - 10:30
  
  State of the art: My experience with interwoven nitinol stent
2. 10:30 - 10:40
  
  Discussion
3. 10:40 - 10:50
  
  Recorded case presentation: CFA: From no go to why not?
4. 10:50 - 11:00
  
  Discussion
10:30 - 11:00, Speakers' corner

Update on innovations, clinical trials, and new data – Treatment of peripheral arterial disease – Carotid

Moderator:

Eugenio Stabile

Moderator:

Piotr Musialek
1. 10:30 - 10:35
  
  Transcervical endovascular treatment of single innominate or common carotid artery stenosis – a meta-analysis
2. 10:35 - 10:40
  
  Incidence of plaque protrusion during carotid artery stenting using micromesh stent
3. 10:40 - 10:45
  
  Long-term results of hybrid and endovascular treatment of multilevel lesions of brachiocephal arteries
4. 10:45 - 10:50
  
  Acute Stroke of CArotid Artery Bifurcation Origin Treated With Use oF the MicronEtcovered CGUARD Stent (SAFEGUARD-STROKE, NCT05195658)
5. 10:50 - 11:00
  
  Discussion and conclusion
11:00 - 11:45, Scientific posters

Moderated poster round – Original research: EVAR, AV, ILIAC, Venous, Visceral

Moderator:

Peter Goverde

Moderator:

Martin Malina
1. 11:00 - 11:05
  
  Controversies of revisional surgery in management of steal syndrome due tohaemodialysis access
2. 11:05 - 11:10
  
  Feasibility and preliminary results of combined use of Gore Iliac Branch Endoprosthesis and Gore Viabahn VBX
3. 11:10 - 11:15
  
  2-year outcomes with Bentley BeGraft as bridging stent-grafts for reno-visceral target vessels during fenestrated endovascular aortic repair
4. 11:15 - 11:20
  
  Single-center experience with inner branched endograft for the treatment of pararenal abdominal aortic aneurysms
5. 11:20 - 11:25
  
  Safety and feasibility of Dynetic-35 cobalt chromium balloon-expandable stent for the treatment of atherosclerotic iliac lesions via a trans-radial approach
6. 11:25 - 11:30
  
  Experience with SQ 53, a novel, patented anti-microbial solution, in management of long-term and medium term central venous catheters
7. 11:30 - 11:35
  
  Validation of Caprini’s Saphenous Ablation Scores
8. 11:35 - 11:40
  
  Shockwave intravascular lithotripsy in revascularisation of calcified superior mesenteric artery: A single-center experience
11:00 - 12:30, Speakers' corner

Update on innovations, clinical trials, and new data – Treatment of peripheral arterial disease – General and AV Shunt

Moderator:

Panagiotis Kitrou
1. 11:00 - 11:05
  
  Gender differences in treatment of ISR lesions with the Pantheris atherectomy catheter
2. 11:05 - 11:10
  
  Sentante – the first fully robotic endovascular thrombectomy
3. 11:10 - 11:15
  
  Acute arterial occlusions in Covid-19 times: A comparison study among patients with acute limb ischemia with or without Covid-19 infection
4. 11:15 - 11:20
  
  Analysis and results of pharmacomechanical thrombectomy with Angiojet in acute arterial occlusions: A prospective comparison study among the number of cycles and outcomes
5. 11:20 - 11:25
  
  Indigo™ thrombectomy system for the treatment of acute occlusion of the superior mesenteric artery
6. 11:25 - 11:30
  
  Endothelial function in patients with critical and non-critical limb ischemia undergoing endovascular treatment
7. 11:30 - 11:35
  
  Use of suture mediated closure device in the treatment of femoral artery pseudoaneurysms
8. 11:35 - 11:40
  
  Comparative outcomes in percutaneous radiological gastrostomy placement techniques
9. 11:40 - 11:45
  
  Sirolimus coated balloons vs plain balloons for dysfunctional AV access in end stage renal disease patients
10. 11:45 - 11:50
  
  Utility of Devansh Ram technique – a novel technique to provide dialysis access in ESRD patients with multiple vascular access failure and thoracic central venous obstruction (TCVO)
11. 11:50 - 11:55
  
  A novel technique of utilising anatomical snuff box for fistula intervention
12. 11:55 - 12:00
  
  Comparison of Reteplase and Urokinase for pharmacomechanical thrombolysis of clotted hemodialysis access in ESRD population
13. 12:00 - 12:30
  
  Discussion and conclusion
11:00 - 12:30, Technical forum

Scrub in with the expert: BTK interventions

Moderator:

Edward Choke

Moderator:

Roberto Ferraresi

Panelist:

Francesco Liistro

Panelist:

Erwin Blessing

Panelist:

Peter Metzger
1. 11:00 - 11:20
  
  Live case transmission from Abano Terme
2. 11:20 - 11:27
  
  Cost/benefit analysis of primary retrograde distal access compared to bail-out distal access in CLI
3. 11:27 - 11:34
  
  Predictors for technical failure in retrograde recanalization
4. 11:34 - 11:54
  
  Live case transmission from Abano Terme
5. 11:54 - 12:01
  
  The wire crossed the lesion, the ballon doesn’t: What else?
6. 12:01 - 12:08
  
  Current data landscape for the BTK space scaffolds
7. 12:08 - 12:30
  
  Live case transmission from Abano Terme
11:15 - 12:30, Main arena 1

Optimizing results of peripheral artery interventions

Moderator:

Ramon Varcoe

Moderator:

Hiroyoshi Yokoi

Panelist:

Masahiko Fujihara

Panelist:

Tatsuya Nakama

Speaker:

Saritphat Orrapin

Panelist:

Brian DeRubertis
1. 11:15 - 11:40
  
  Live case transmission from Osaka
2. 11:40 - 11:46
  
  The impact of intravascular ultrasound on femoropopliteal artery endovascular interventions – a randomized controlled trial
3. 11:46 - 11:52
  
  The optimal endpoint of DCB treatment assessed by IVUS – insights from the Japanese multicenter registry
4. 11:52 - 11:58
  
  Cost utility analysis of IVUS guided treatment of femoropopliteal artery revascularisation in Germany
5. 11:58 - 12:04
  
  Comparing the impact of the loss of patency between treatment with drug-coated balloon angioplasty and drug-eltuing stent placement
6. 12:04 - 12:10
  
  RECOIL study: Core lab adjudicated study to assess recoil after scoring PTA vs POBA
7. 12:10 - 12:16
  
  The value of Tack devices to optimize femoropopliteal interventions: Latest data and indications
8. 12:16 - 12:22
  
  Second-generation low-dose drug-coated balloon vs high-dose drug-coated balloon for symptomatic femoropopliteal artery disease: The result from the PROSPECT-MONSTER study
9. 12:22 - 12:30
  
  Discussion and conclusion
11:45 - 12:30, Main arena 2

Choice of bridging stents in complex aortic repair: What is available, what is the evidence?

Moderator:

Nikolaos Tsilimparis

Moderator:

Martin Austermann

Panelist:

Luca Bertoglio

Panelist:

Jean-Paul de Vries

Panelist:

Jorge Fernández Noya

Panelist:

Michele Piazza

Panelist:

Mario Lescan
1. 11:45 - 11:49
  
  3D geometrical analysis of bridging stentgrafts post FEVAR classifies modes of failures and guides reinterventions
2. 11:49 - 11:53
  
  Bridging stent geometrical determinant of target vessel instability in FEVAR
3. 11:53 - 11:57
  
  Mid-term real-world evidence of VBX in fEVAR: results from EXPAND postmarket registry
4. 11:57 - 12:01
  
  Update on FEVAR trial for bridging stents
5. 12:01 - 12:05
  
  Single centre experience of bridging stent durability in FEVAR
6. 12:05 - 12:09
  
  Preliminary experience and mid term results of VBX in combination with a fenestrated device. Key results and takeaways in real world setting
7. 12:09 - 12:13
  
  Gore VBX as briding stent in fenestrated and branched repair: EMBRACE Study outlines and objectives
8. 12:13 - 12:17
  
  VBX in bEVAR. 2-year follow-up from EXPAND registry and Münster experience
9. 12:17 - 12:21
  
  Update on BEVAR trial for bridging stents
10. 12:21 - 12:30
  
  Panel discussion
12:30 - 13:15, Main arena 1

LUNCH SYMPOSIUM: Endovascular treatment algorithms for the management of complex calcified lesions: A case based discussion

supported by CSI

Moderator:

Dierk Scheinert

Panelist:

Konstantinos Katsanos

Panelist:

Michael Lichtenberg
1. 12:30 - 12:37
  
  Opening
2. 12:37 - 12:44
  
  Device overview and mechanism of action
3. 12:44 - 12:52
  
  Case 1: ATK
4. 12:52 - 12:57
  
  Q&A
5. 12:57 - 13:05
  
  Case 2: BTK
6. 13:05 - 13:10
  
  Q&A
7. 13:10 - 13:15
  
  Session recap and close
12:30 - 13:15, Main arena 2

LUNCH SYMPOSIUM: I ❤️ iBevar because …

supported by Artivion

Moderator:

Hence Verhagen

Moderator:

Lee Bouwman

Panelist:

Theodosios Bisdas

Panelist:

Sébastien Déglise

Panelist:

Said Abisi
1. 12:30 - 12:40
  
  … it gives me consistent approach and results across pathologies (aneurysms, dissections, other)
2. 12:40 - 12:50
  
  … I can use it in elective as well as emergent and urgent cases
3. 12:50 - 13:00
  
  … multicenter data show consistent results
4. 13:00 - 13:15
  
  Discussion and conclusion
12:30 - 13:30, Speakers' corner

Challenging cases and complications: TEVAR

Moderator:

Marc van Sambeek

Moderator:

Martin Malina
1. 12:30 - 12:35
  
  Percutaneous assistance to aortic open surgery for ascending aorta pseudoaneurysms
2. 12:35 - 12:40
  
  Endovascular management of Aorto-cava fistula due to thoracoabdominal stab trauma: A rare case report in a Level I hospital in Colombia
3. 12:40 - 12:45
  
  Staged hybrid treatment of pseudoaneurysm of subclavian-aortic bypass as late complication for aortic interruption surgical correction
4. 12:45 - 12:50
  
  Transapical endovascular stent-graft and plug embolization for suture line ascending aorta pseudoaneurysm repair: Do we reach the moon from the front door
5. 12:50 - 12:55
  
  Endovascular treatment of an ascending aorta pseudo-aneurysm with cutaneous fistula using trans-apical approach
6. 12:55 - 13:00
  
  Accidental coverage of left common carotid artery after TEVAR for DeBakey Type III aortic dissection – case report
7. 13:00 - 13:05
  
  Bail out method with Outback® for the false lumen insertion of the frozen elephant trunk for Type A dissection
8. 13:05 - 13:10
  
  Challenging plug closure for ascending aortic pseudoaneurysms post TAVI using Evolut-Pro
9. 13:10 - 13:15
  
  A failed full deployment of a thoracic aortic stent-graft managed successfully by a balloon dilatation and rapid pacing induced hypotension
10. 13:15 - 13:30
  
  Discussion and conclusion
12:30 - 13:15, Technical forum

LUNCH SYMPOSIUM: Sirolimus Coated Balloon in PAD treatment: Conquering the complexities

supported by Concept Medical

Moderator:

Sahil Parikh

Moderator:

Dierk Scheinert

Panelist:

Brian DeRubertis

Panelist:

Masahiko Fujihara

Panelist:

Tatsuya Nakama

Panelist:

Osamu Iida

Panelist:

Marcus Thieme
1. 12:30 - 12:32
  
  Introduction and session objectives
2. 12:32 - 12:36
  
  Case presentation: Sirolimus coated balloon for BTK/BTA with no slow flow phenomenon
3. 12:36 - 12:40
  
  Discussion
4. 12:40 - 12:48
  
  Case presentation: Sirolimus magic touch DCB in complex BTK recanalization
5. 12:48 - 12:52
  
  Discussion
6. 12:52 - 13:00
  
  Case presentation 3
7. 13:00 - 13:04
  
  Discussion
8. 13:04 - 13:08
  
  Case presentation: Sirolimus coated balloon for case of severe occlusive disease secondary to Polyarteritis Nodosa
9. 13:08 - 13:15
  
  Discussion and conclusion
13:00 - 13:45, Scientific posters

Moderated poster round – Challenging cases: BTK, CLI, Femoral, PVD, SFA

Moderator:

Sigrid Nikol

Moderator:

Jos van den Berg
1. 13:00 - 13:05
  
  Alternative arterial access in PAD
2. 13:05 - 13:10
  
  Staged PTA of lower extremity in advanced diabetic foot
3. 13:10 - 13:15
  
  Percutaneous intervention to treat failed Angio-Seal deployment
4. 13:15 - 13:20
  
  Hybrid treatment of critical limb ischemia in a patient with multilevel peripheral arterial disease and high risk for bleeding – a challenging case
5. 13:20 - 13:25
  
  Limb flexion-induced axial compression of bare metal stent
6. 13:25 - 13:30
  
  Remote endarterectomy of external iliac (EIA) and Superficial Femoral arteries (SFA) as a successful inflow for Anterior tibial artery (ATA) bypass graft; an alternative to inadequate vein conduit length
7. 13:30 - 13:35
  
  The optimization techniques to use the intravascular imaging technology for peripheral endovascular intervention in patients with peripheral arterial disease
8. 13:35 - 13:40
  
  Multiple complications during femoro-popliteal angioplasty
9. 13:40 - 13:45
  
  Undersized Supera stent in the superficial femoral artery can work as a coil
13:30 - 15:15, Main arena 1

The last frontiers: Treatment of challenging CTO’s, in-stent-restenoses and thrombus-containing lesions

Moderator:

Gary Ansel

Moderator:

Hans Krankenberg

Panelist:

Yvonne Bausback

Panelist:

Miguel Montero

Panelist:

Lieven Maene

Panelist:

Michael Piorkowski
1. 13:30 - 13:36
  
  Zilverpass: 5-year results of DES vs Bypass and economical analysis
2. 13:36 - 13:42
  
  Should we be trying to remove thrombus before definitive treatment in subacute thrombotic CTO’s
3. 13:42 - 13:57
  
  Recorded case presentation: Penumbra Lightning™; the intelligent aspiration system to have, designed for Frontline Aspiration in Acute Limb Ischemia
4. 13:57 - 14:03
  
  Outcome of percutaneous mechanical thrombectomy followed by catheter directed thrombolysis
5. 14:03 - 14:09
  
  Rotational atherectomy plus DCB for the treatment of SFA in-stent restenosis
6. 14:09 - 14:15
  
  FIRST TIME DATA RELEASE: Final 24 months results of the Rotarex post market study
7. 14:15 - 14:45
  
  Live case transmission from Leipzig
8. 14:45 - 14:50
  
  When femoral access is not working, - alternative access methods for PAD treatment
9. 14:50 - 14:56
  
  BeBack crossing and re-entry catheter – my experiences (CTOs + sharp recanalization)
10. 14:56 - 15:02
  
  Gore Viabahn for in-stent restenosis in the SFA evaluated at 3-years
11. 15:02 - 15:08
  
  Update on the PQ-Bypass concept
12. 15:08 - 15:15
  
  Live case wrap up and discussion
13:30 - 14:15, Main arena 2

Strategies to optimize the outcome of EVAR procedures: What is availabale? What is useful? What is too much?

Moderator:

Marc van Sambeek

Panelist:

Hence Verhagen

Panelist:

Michel Reijnen

Panelist:

Daniela Branzan

Panelist:

Michele Piazza
1. 13:30 - 13:38
  
  The evolution of the aneurysms sac after EVAR: What do we know?
2. 13:38 - 13:46
  
  Prophylactic embolization during EVAR to prevent Type 2 Endoleak: Routine, selective, sac-focused? The Leipzig strategy: Technical details and results
3. 13:46 - 13:56
  
  Panel discussion
4. 13:56 - 14:04
  
  Active aneurysm sac management during EVAR with sac filling technologies: What is available and when do I use it?
5. 14:04 - 14:15
  
  Panel discussion
13:30 - 14:45, Speakers' corner

Update on innovations, clinical trials, and new data – EVAR

Moderator:

Giovanni Torsello

Moderator:

Antoine Millon
1. 13:30 - 13:35
  
  Morphological and functional analysis of endovascular repair with embedded modular branched stent graft for aortic arch aneurysm
2. 13:35 - 13:40
  
  Initial experience with the dual branch NEXUS DUO™ aortic arch stent graft system
3. 13:40 - 13:45
  
  E-nside TAAA multibranch stent graft in the treatment of thoracoabdominal aortic aneurysms (TAAA): Early results of the INNER-B study
4. 13:45 - 13:50
  
  A systematic review and meta-analysis of outcomes of stent-graft complexity for the management of complex abdominal aortic aneurysms
5. 13:50 - 13:55
  
  Automatic aortic volume measurement using innovative AI solution EndoArt
6. 13:55 - 14:00
  
  A New Technique of endovascular scissoring to manage visceral malperfusion in complicated post chronic Type B dissection ruptured thoracic aortic aneurysm
7. 14:00 - 14:05
  
  Initial results of physician-modified inner branched endovascular repair in high surgical risk patients
8. 14:05 - 14:10
  
  Preliminary experience with intravascular lithotripsy and low profile endografts in endovascular abdominal aneurysm repair with heavily calcified access
9. 14:10 - 14:15
  
  Misalignment in FEVAR. Technique to ensure cannulation of target arteries in PMEG: In vitro test. Proposal for an off the shelf device
10. 14:15 - 14:20
  
  The E-tegra stent graft system in the treatment of infrarenal aortic aneurysms: First results of the European multicentre EASY study
11. 14:20 - 14:25
  
  Results from the Frontier V study of a novel fully bioabsorbable large hole vascular closure device
12. 14:25 - 14:45
  
  Discussion and conclusion
13:30 - 15:30, Technical forum

LINC Compact – Hot topics 2023 – Innovative-Relevant-Controversial – part I

Moderator:

Steven Kum

Moderator:

Dierk Scheinert

Panelist:

Chris Metzger

Panelist:

Yann Gouëffic

Panelist:

Ralf Langhoff

Panelist:

Brian DeRubertis
1. 13:30 - 13:37
  
  Critical limb-threatening ischemia and BTK interventions: New approaches for assessment of procedural outcomes and surveillance
2. 13:37 - 13:44
  
  Critical limb-threatening ischemia and BTK interventions: Treatment of CLTI after BEST-CLI and BASIL 2: Implications for our practice
3. 13:44 - 13:51
  
  Critical limb-threatening ischemia and BTK interventions: What is really BEST interventional practice to treat CLI?
4. 13:51 - 13:58
  
  Critical limb-threatening ischemia and BTK interventions: Deep venous arterialization for patients with CLTI: Real hope or hype?
5. 13:58 - 14:15
  
  Panel discussion
6. 14:15 - 14:22
  
  Carotid interventions: Best practice for carotid interventions in 2023
7. 14:22 - 14:29
  
  Carotid interventions: Why is TCAR through direct puncture of the carotid artery a valid alternative?
8. 14:29 - 14:34
  
  Panel discussion
9. 14:34 - 14:41
  
  Aortoiliac and femoral interventions: Advanced techniques for aortoiliac and femoral CTO’s: The value of alternative access routes
10. 14:41 - 14:48
  
  Aortoiliac and femoral interventions: Are covered stents the new standard for aortoiliac interventions in 2023? Yes, results with covered stents are generally superior
11. 14:48 - 14:55
  
  Aortoiliac and femoral interventions: Are covered stents the new standard for aortoiliac interventions in 2023? No, bare metal stents are mostly sufficient generally superior
12. 14:55 - 15:00
  
  Panel discussion
13. 14:58 - 15:07
  
  Aortoiliac and femoral interventions: Drug-eluting devices in the femoropopliteal segement: Standards for lower extremity artery disease evaluation with IVUS: Japanese expert consensus’
14. 15:07 - 15:14
  
  Aortoiliac and femoral interventions: Drug-eluting devices in the femoropopliteal segement: Pro and Contra Paclitaxel coated devices set the benchmark and are here to stay
15. 15:14 - 15:21
  
  Aortoiliac and femoral interventions: Sirolimus and other –limus drug coatings will be the future
16. 15:21 - 15:30
  
  Panel discussion
14:15 - 17:00, Main arena 2

Pioneering solutions for complex TAAA and pathologies involving the aortic arch

Moderator:

Tilo Kölbel

Moderator:

Nikolaos Tsilimparis

Panelist:

Michael Borger
1. 14:15 - 14:20
  
  Endoanchors can be safely deployed in the thoracic aorta to strengthen your sealing zones
2. 14:20 - 14:55
  
  Live case transmission from Hamburg
3. 14:55 - 15:00
  
  Focus on solutions for the left subclavian artery: Onlabel InSitu LSA fenestration during TEVAR
4. 15:00 - 15:05
  
  Focus on solutions for the left subclavian artery: Anatomical feasibility of needle in-situ fenestration of the left subclavian artery during TEVAR
5. 15:05 - 15:10
  
  Focus on solutions for the left subclavian artery: Challenging case by Insitu Fenestration
6. 15:10 - 15:15
  
  Focus on solutions for the left subclavian artery: 1-year results with the WeFlow graft for TEVAR with subclavian artery reconstructions
7. 15:15 - 15:20
  
  Focus on solutions for the left subclavian artery: TEVAR in landing zone 2: How durable is the seal after debranching of the LSA
8. 15:20 - 15:25
  
  Focus on solutions for aortic arch aneurysms: The optimal endovascular treatment of complex aortic arch aneurysms from simple scalloped to triple branch devices
9. 15:25 - 15:30
  
  Focus on solutions for aortic arch aneurysms: Development and clincial practice of minimally invasive treatment device for aortic arch
10. 15:30 - 15:35
  
  Focus on solutions for aortic arch aneurysms: The GIANT study: Initial results with the WeFlow-Bubranch stent-graft
11. 15:35 - 15:40
  
  Focus on solutions for aortic arch aneurysms: Endovasculare aortic arch repair with the transaxillary branch to branch technique to avoid exposure of the supra-aortic vessels. Initial experience
12. 15:40 - 15:45
  
  Focus on solutions for aortic arch aneurysms: State of the art surgical solutions for aortic arch reconstruction
13. 15:45 - 16:15
  
  Live case transmission from Hamburg
14. 16:15 - 16:20
  
  Focus on overcoming challenging situations and managing/preventing complications: Stroke prevention in TEVAR: New concepts to minimize brain damage
15. 16:20 - 16:25
  
  Focus on overcoming challenging situations and managing/preventing complications: A mechanical aortic valve is no reason not to perform arch branched repair at zone 0 – tips and tricks
16. 16:25 - 16:30
  
  Focus on overcoming challenging situations and managing/preventing complications: Redo procedures with T-Branch
17. 16:30 - 16:35
  
  Focus on overcoming challenging situations and managing/preventing complications: How to manage TEVAR failures requiring open conversion
18. 16:35 - 17:00
  
  Discussion and conclusion
14:45 - 16:00, Speakers' corner

Challenging cases and complications: PVD/femoral

Moderator:

Jos van den Berg

Moderator:

Sigrid Nikol
1. 14:45 - 14:50
  
  Complications after fogarty catheter embolectomy – peroneal pseudoaneurysm and arteriovenous fistula
2. 14:50 - 14:55
  
  IVUS guided endoluminal bypass in a case of long occlusive femoral disease
3. 14:55 - 15:00
  
  A case of successful treatment with EVT for CFA occlusion after stent grafting for abdominal aortic aneurysm
4. 15:00 - 15:05
  
  Modified sheath reversal and performing one-stage angioplasty of both CLTI’s legs using one CFA access
5. 15:05 - 15:10
  
  A case of acute lower limb ischemia in the long-term period after femoropopliteal bypass surgery, that was successfully treated with hybrid therapy
6. 15:10 - 15:15
  
  Angioseal stuck anchor unlocking method
7. 15:15 - 15:20
  
  Revascularization of critical limb ischemia due to popliteal artery aneurysm thrombosis with rotational mechanical thrombectomy and braided selfexpanding stents
8. 15:20 - 15:25
  
  Endovascular treatment of giant groin pseudoaneurysm after large bore closure device implantation – case report
9. 15:25 - 15:30
  
  Acute limb ischemia with multiple stenotic lesions
10. 15:30 - 16:00
  
  Discussion and conclusion
15:15 - 16:30, Main arena 1

The last frontiers: Interventional treatment of BTK and BTA vessels in diabetics

Moderator:

Luis Mariano Palena

Moderator:

Peter Schneider

Panelist:

Daniel van den Heuvel

Panelist:

Giacomo Clerici

Panelist:

Roberto Ferraresi

Panelist:

Wuttichai Saengprakai
1. 15:15 - 15:22
  
  Why does medial artery calcification lead to SAD? A numerical model based analysis of endothelial shear stress could explain
2. 15:22 - 15:52
  
  Live case transmission from Abano Terme
3. 15:52 - 15:59
  
  Latest techniques for retrograde crossing of BTK-CTOs
4. 15:59 - 16:04
  
  Technical success and clinical results of endovascular therapy in diabetic patients with high grade of medial artery calcification
5. 16:04 - 16:11
  
  What is the real prevalence of no-option anatomy amongst CLTI-patients?
6. 16:11 - 16:18
  
  Diabetic foot: A syndrome that needs a multidisciplinary approach and multimodal therapy
7. 16:18 - 16:25
  
  Home monitoring of tissue perfusion post PTA predicts clinical outcome of CLTI patients

Notice

LINC 2023 Programme

LINC 2023 programme

Conference day 1

OPENING SYMPOSIUM: Saving limbs: How a broader PAD approach improves patients' treatment

Beyond intervention: Our most important learnings from the journey

Discussion

Live case transmission from Leipzig

Discussion

How to prevent amputation – my experience working as a multidisciplinary team

Round table discussion

Acute venous thromboembolism

Live case transmission from Galway

Effectiveness and safety of ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism: A multinational individual-level data analysis of more than 1500 patients

FlowTriever embolectomy for acute pulmonary embolism

Rationale of a pivotal randomized trial comparing aspiration thrombectomy vs medical therapy for intermediate high risk pulmonary embolism

Live case transmission from Galway

Prospective post-market clinical follow-up study of the Aspirex™ endovascular thrombectomy system in the treatment of acute venous occlusions – 12-month update

Catheter-directed thrombolysis and pharmacomechanical thrombectomy for acute deep vein thrombosis

Recorded case presentation: New technology to address DVT Management and Pulmonary Artery Treatment: Penumbra Lightning™ 12 system, designed for Frontline Aspiration

Endovascular theombectomy for accute PE with shock

Discussion

Status update: Carotid interventions 2023

Carotid repair is best for asymptomatic carotid stenosis because medical management alone does not work

Update on the CEA vs CAS trials for asymptomatic carotid stenosis

Interventions in acute carotid syndrome: When and how?

Why guidelines can be misleading: Carotid guidelines are an example

Panel discussion

Focus on latest technique and new devices: Local anaesthesia and intraoperative ultrasound are the key for an uncomplicated carotid endarterectomy

Focus on latest technique and new devices: TCAR is better than true percutaneous carotid stenting: Myth or reality?

Focus on latest technique and new devices: Risk factors of stroke in patients undergoing transcervical and transfemoral carotid stenting

Focus on latest technique and new devices: FIRST TIME DATA RELEASE: 30-day safety outcomes of male vs female patients treated using the Roadsaver dual-layer micromesh carotid stent: Evidence from a large multicenter European study

Focus on latest technique and new devices: FIRST TIME DATA RELEASE: 30-day safety outcomes of patients treated using the Roadsaver dual-layer micromesh carotid stent with or without predilatation: Evidence from a large multicenter European study

Live case transmission from Münster

Focus on latest technique and new devices: How to select endovascular protection devices for CAS

Focus on latest technique and new devices: Proximal protection during carotid artery stenting: A preferred solution for all patients

Focus on latest technique and new devices: Carotid artery stenting with proximal protection: How to optimize your outcomes

Focus on latest technique and new devices: Experiences from a high volume carotid artery stenting center: Improving safety with proximal protection

Focus on future concepts: Acute stroke interventions – step-by-step

Focus on future concepts: Percutaneous exclusion of carotid artery aneurysms: Insights from the C-Heal-trial

Focus on future concepts: AI with specific algorythms could predict carotid risk lesions for stroke: Revolutionary tool or fake?

Live case recap and discussion

CONNECT THE WORLD SESSION: JAPAN – in collaboration with JET – Innovations and latest data in femoropopliteal interventions

Live case transmission from Tokyo

FIRST TIME DATA RELEASE: Ranger SFA II RCT (Ranger DCB vs POBA) – 3 year patency and 4 year clinical/safety

Prospective, multicenter registry of drug-coated balloon treatment for peripheral artery disease: Results from the Japan POPCORN registry

Korean multicenter prospective registry of IN.PACT drug-coated balloon for Popliteal Artery Disease (K-POP Study)

1-year outcomes after Paclitaxel-coated balloon angioplasty of femoropopliteal arteries among patients in the french national health data system

FIRST TIME DATA RELEASE: ELEGANCE registry: DET in under-represented groups – Initial results in the first 750 patients with Ranger DCB

Live case transmission from Leipzig

FIRST TIME DATA RELEASE: TINTIN trial investigating the combination of DCB and bare metal stents: 4-year result

FIRST TIME DATA RELEASE: Real world all comers data from the REGAL registry – 2-year results

3-year results of the CAPSICUM study

Advancing SFA lesion treatment with NiTiDES™ self-expanding DES

A patient-level pooled analysis of drug-coated balloons vs bare metal stents for the treatment of symptomatic femoropopliteal disease

Live case recap and discussion

Ablation therapy for superficial venous disease

What are the treatment options for Saphenous Ablation?

When is the VenaSeal Closure system appropriate for patients?

Single center experience on Saphenous Vein Incompetence study

Trial updates for chronic venous disease patients enrolled in the spectrum study program: Study design and current status

Panel discussion

Moderated poster round – Challenging cases: AV, Venous, Visceral

Endovascular removal of a dislodged Supera stent from a dialysis access arterio-venous graft

Mechanical thrombectomy in acute thrombosis of dialysis arteriovenous fistulae

Spectrum of complications associated with hemodialysis catheter insertion

Innovative and effective solution for treating dysfunctional AV access

Large pulmonary emboli and paradoxical embolism treated with catheter directed thrombolysis

Challenging endovascular treatment of a cephalic arch stent fracture in brachiocephalic arteriovenous fistulae

Acoustic pulse thrombolysis (EKOS), and a suprarenal inferior vena cava filter for the treatment of extensive Inferior Vena Cava thrombosis over pervious Inferior vena cava filter in a case of antithrombin III deficiency

Iliac vein compression with significant limb swelling caused by lumbosacral exostosis. Its elimination by iliac vein stenting

A successful case of catheter-directed thrombolysis in a patient with deep vein thrombosis due to idiopathic eosinophilia

Successful retrieval of an intravascular foreign body using ONE Snare® system

Surgical bail out after failed endovascular revascularisation for mesenteric ischaemia in systemic lopus victim

SYMPOSIUM: From RCTs, to real world, to big data. Moving forward with drug eluting technologies for PAD

RCT data, the pinnacle of proof

Real world data

Real world data from Japan

Big data from big databases

Panel discussion: Where we have been, what we have learnt, where we are going.